Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. The FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory. The NDC contains over 97,000 entries; this list contains a small set of sample records illustrating the fields contained in the full list. View the API output for the full set of 11 fields contained in this dataset.
Proprietary Drug Name | Generic Name | Dosage Type | Product Type | Start Date | End Date | Primary Substance | Marketing Category | Application Number | Numberator/Strength | Active Ingredient |
---|---|---|---|---|---|---|---|---|---|---|
Acular | Ketorolac Tromethamine | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 12/01/1992 | 01/01/1900 | Ketorolac Tromethamine | NDA | NDA019700 | 5 | mg/mL |
ACULAR LS | ketorolac tromethamine | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 08/19/2003 | 01/01/1900 | Ketorolac Tromethamine | NDA | NDA021528 | 4 | mg/mL |
ACUVAIL | ketorolac tromethamine | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 08/01/2009 | 01/01/1900 | Ketorolac Tromethamine | NDA | NDA022427 | 4.5 | mg/mL |
ACZONE | dapsone | Gel | HUMAN PRESCRIPTION DRUG | 06/24/2009 | 01/01/1900 | Dapsone | NDA | NDA021794 | 50 | mg/g |
Afrezza | Insulin Human | Powder, Metered | HUMAN PRESCRIPTION DRUG | 07/11/2014 | 01/01/1900 | Insulin Human | NDA | NDA022472 | 4 | 42005 |
Afrezza | Insulin Human | Kit | HUMAN PRESCRIPTION DRUG | 07/11/2014 | 01/01/1900 | NDA | NDA022472 | |||
Afrezza | Insulin Human | Kit | HUMAN PRESCRIPTION DRUG | 07/11/2014 | 01/01/1900 | NDA | NDA022472 | |||
Afrezza | Insulin Human | Kit | HUMAN PRESCRIPTION DRUG | 07/11/2014 | 01/01/1900 | NDA | NDA022472 | |||
Albuminar-20 | Albumin (Human) | Solution | PLASMA DERIVATIVE | 01/06/2009 | 01/01/1900 | Albumin Human | BLA | BLA103955 | 20 | g/100mL |
Albuminar-25 | Albumin (Human) | Solution | PLASMA DERIVATIVE | 01/06/2009 | 01/01/1900 | Albumin Human | BLA | BLA103955 | 25 | g/100mL |
Albuminar-5 | Albumin (Human) | Solution | PLASMA DERIVATIVE | 01/06/2009 | 01/01/1900 | Albumin Human | BLA | BLA103955 | 2.5 | g/50mL |
ALDACTAZIDE | spironolactone and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/1978 | 01/01/1900 | Hydrochlorothiazide; Spironolactone | NDA | NDA012616 | 25; 25 | mg/1; mg/1 |
ALDACTAZIDE | spironolactone and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/1978 | 01/01/1900 | Hydrochlorothiazide; Spironolactone | NDA | NDA012616 | 50; 50 | mg/1; mg/1 |
Aldactone | spironolactone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/21/1960 | 01/01/1900 | Spironolactone | NDA | NDA012151 | 100 | mg/1 |
Aldactone | spironolactone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/21/1960 | 01/01/1900 | Spironolactone | NDA | NDA012151 | 50 | mg/1 |
Aldactone | spironolactone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/21/1960 | 01/01/1900 | Spironolactone | NDA | NDA012151 | 25 | mg/1 |
Alimta | Pemetrexed disodium | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 02/13/2004 | 01/01/1900 | Pemetrexed Disodium Heptahydrate | NDA | NDA021462 | 500 | mg/20mL |
Alimta | Pemetrexed disodium | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/15/2008 | 01/01/1900 | Pemetrexed Disodium Heptahydrate | NDA | NDA021462 | 100 | mg/4mL |
ALOCRIL | nedocromil sodium | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 02/03/2000 | 01/01/1900 | Nedocromil Sodium | NDA | NDA021009 | 20 | mg/mL |
ALPHAGAN P | brimonidine tartrate | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 07/10/2001 | 01/01/1900 | Brimonidine Tartrate | NDA | NDA021262 | 1.5 | mg/mL |
ALPHAGAN P | brimonidine tartrate | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 01/25/2006 | 01/01/1900 | Brimonidine Tartrate | NDA | NDA021770 | 1 | mg/mL |
ALTABAX | retapamulin | Ointment | HUMAN PRESCRIPTION DRUG | 05/02/2007 | 01/01/1900 | Retapamulin | NDA | NDA022055 | 10 | mg/g |
AMARYL | glimepiride | Tablet | HUMAN PRESCRIPTION DRUG | 06/18/2009 | 01/01/1900 | Glimepiride | NDA | NDA020496 | 1 | mg/1 |
AMARYL | glimepiride | Tablet | HUMAN PRESCRIPTION DRUG | 06/18/2009 | 01/01/1900 | Glimepiride | NDA | NDA020496 | 2 | mg/1 |
AMARYL | glimepiride | Tablet | HUMAN PRESCRIPTION DRUG | 06/18/2009 | 01/01/1900 | Glimepiride | NDA | NDA020496 | 4 | mg/1 |
Ambien | zolpidem tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/01/1993 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA019908 | 5 | mg/1 |
Ambien | zolpidem tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/01/1993 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA019908 | 10 | mg/1 |
Ambien | zolpidem tartrate | Tablet, Coated | HUMAN PRESCRIPTION DRUG | 09/19/2005 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA021774 | 6.25 | mg/1 |
Ambien | zolpidem tartrate | Tablet, Coated | HUMAN PRESCRIPTION DRUG | 09/19/2005 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA021774 | 12.5 | mg/1 |
AMINOHIPPURATE SODIUM | aminohippurate sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/30/1944 | 01/01/1900 | Aminohippurate Sodium | NDA | NDA005619 | 2 | g/10mL |
Amlodipine Besylate | Amlodipine Besylate | Tablet | HUMAN PRESCRIPTION DRUG | 07/09/2007 | 01/01/1900 | Amlodipine Besylate | ANDA | ANDA077262 | 2.5 | mg/1 |
Amlodipine Besylate | Amlodipine Besylate | Tablet | HUMAN PRESCRIPTION DRUG | 07/09/2007 | 01/01/1900 | Amlodipine Besylate | ANDA | ANDA077262 | 5 | mg/1 |
Amlodipine Besylate | Amlodipine Besylate | Tablet | HUMAN PRESCRIPTION DRUG | 07/09/2007 | 01/01/1900 | Amlodipine Besylate | ANDA | ANDA077262 | 10 | mg/1 |
Amyvid | Florbetapir F 18 | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/01/2012 | 01/01/1900 | Florbetapir F-18 | NDA | NDA202008 | 51 | mCi/mL |
Anaprox | naproxen sodium | Tablet | HUMAN PRESCRIPTION DRUG | 09/04/1980 | 01/01/1900 | Naproxen Sodium | NDA | NDA018164 | 275 | mg/1 |
Anaprox DS | naproxen sodium | Tablet | HUMAN PRESCRIPTION DRUG | 09/04/1980 | 01/01/1900 | Naproxen Sodium | NDA | NDA018164 | 550 | mg/1 |
Androgel | Testosterone | Gel | HUMAN PRESCRIPTION DRUG | 03/14/2011 | 01/01/1900 | Testosterone | NDA | NDA021015 | 10 | mg/g |
Androgel | Testosterone | Gel | HUMAN PRESCRIPTION DRUG | 03/14/2011 | 01/01/1900 | Testosterone | NDA | NDA021015 | 10 | mg/g |
Androgel | Testosterone | Gel | HUMAN PRESCRIPTION DRUG | 04/29/2011 | 01/01/1900 | Testosterone | NDA | NDA022309 | 16.2 | mg/g |
Androgel | Testosterone | Gel | HUMAN PRESCRIPTION DRUG | 03/14/2011 | 01/01/1900 | Testosterone | NDA | NDA021015 | 10 | mg/g |
ANTIVENIN | Latrodectus mactans | Kit | PLASMA DERIVATIVE | 12/01/2014 | 01/01/1900 | BLA | BLA101062 | |||
ANTIVENIN (MICRURUS FULVIUS) | antivenin (micrurus fulvius) | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/1967 | 01/01/1900 | North American Coral Snake Antivenin (micrurus Fulvius) (equine) | BLA | BLA101099 | 1 | g/10mL |
Antivert | MECLIZINE HYDROCHLORIDE | Tablet | HUMAN PRESCRIPTION DRUG | 04/11/1997 | 01/01/1900 | Meclizine Hydrochloride | NDA | NDA010721 | 12.5 | mg/1 |
Antivert | MECLIZINE HYDROCHLORIDE | Tablet | HUMAN PRESCRIPTION DRUG | 04/11/1997 | 01/01/1900 | Meclizine Hydrochloride | NDA | NDA010721 | 25 | mg/1 |
Antivert | MECLIZINE HYDROCHLORIDE | Tablet | HUMAN PRESCRIPTION DRUG | 04/11/1997 | 01/01/1900 | Meclizine Hydrochloride | NDA | NDA010721 | 50 | mg/1 |
Aplenzin | bupropion hydrobromide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 03/30/2009 | 03/31/2017 | Bupropion Hydrobromide | NDA | NDA022108 | 174 | mg/1 |
Aplenzin | bupropion hydrobromide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 03/30/2009 | 03/31/2017 | Bupropion Hydrobromide | NDA | NDA022108 | 348 | mg/1 |
Aplenzin | bupropion hydrobromide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 03/30/2009 | 01/01/1900 | Bupropion Hydrobromide | NDA | NDA022108 | 522 | mg/1 |
ARGATROBAN | argatroban | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/28/2000 | 01/01/1900 | Argatroban | NDA | NDA020883 | 100 | mg/mL |
ARIXTRA | fondaparinux sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/30/2005 | 10/31/2016 | Fondaparinux Sodium | NDA | NDA021345 | 2.5 | mg/.5mL |
ARIXTRA | fondaparinux sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/17/2004 | 11/30/2016 | Fondaparinux Sodium | NDA | NDA021345 | 5 | mg/.4mL |
ARIXTRA | fondaparinux sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/17/2004 | 11/30/2016 | Fondaparinux Sodium | NDA | NDA021345 | 7.5 | mg/.6mL |
ARIXTRA | fondaparinux sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/17/2004 | 09/30/2016 | Fondaparinux Sodium | NDA | NDA021345 | 10 | mg/.8mL |
Aromasin | exemestane | Tablet | HUMAN PRESCRIPTION DRUG | 10/21/1999 | 01/01/1900 | Exemestane | NDA | NDA020753 | 25 | mg/1 |
ARRANON | nelarabine | Injection | HUMAN PRESCRIPTION DRUG | 01/19/2006 | 01/01/1900 | Nelarabine | NDA | NDA021877 | 5 | mg/mL |
ARTHROTEC | diclofenac sodium and misoprostol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/24/1997 | 01/01/1900 | Diclofenac Sodium; Misoprostol | NDA | NDA020607 | 50; 200 | mg/1; ug/1 |
ARTHROTEC | diclofenac sodium and misoprostol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/24/1997 | 01/01/1900 | Diclofenac Sodium; Misoprostol | NDA | NDA020607 | 75; 200 | mg/1; ug/1 |
Astelin | azelastine hydrochloride | Spray, Metered | HUMAN PRESCRIPTION DRUG | 11/15/1996 | 11/30/2016 | Azelastine Hydrochloride | NDA | NDA020114 | 137 | ug/1 |
Astepro | Azelastine Hydrochloride | Spray, Metered | HUMAN PRESCRIPTION DRUG | 10/12/2009 | 01/01/1900 | Azelastine Hydrochloride | NDA | NDA022371 | 205.5 | ug/1 |
Atgam | EQUINE THYMOCYTE IMMUNE GLOBULIN | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/17/1981 | 01/01/1900 | Equine Thymocyte Immune Globulin | BLA | BLA103676 | 50 | mg/mL |
Auvi-Q | epinephrine | Injection | HUMAN PRESCRIPTION DRUG | 11/15/2012 | 01/01/1900 | Epinephrine | NDA | NDA201739 | 0.15 | mg/1 |
Auvi-Q | epinephrine | Injection | HUMAN PRESCRIPTION DRUG | 11/15/2012 | 01/01/1900 | Epinephrine | NDA | NDA201739 | 0.3 | mg/1 |
AVAGE | tazarotene | Cream | HUMAN PRESCRIPTION DRUG | 01/07/2003 | 01/01/1900 | Tazarotene | NDA | NDA021184 | 1 | mg/g |
Avalide | irbesartan and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2013 | 01/01/1900 | Hydrochlorothiazide; Irbesartan | NDA | NDA020758 | 12.5; 150 | mg/1; mg/1 |
Avalide | irbesartan and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2013 | 01/01/1900 | Hydrochlorothiazide; Irbesartan | NDA | NDA020758 | 12.5; 300 | mg/1; mg/1 |
Avapro | irbesartan | Tablet | HUMAN PRESCRIPTION DRUG | 01/01/2013 | 01/01/1900 | Irbesartan | NDA | NDA020757 | 75 | mg/1 |
Avapro | irbesartan | Tablet | HUMAN PRESCRIPTION DRUG | 01/01/2013 | 01/01/1900 | Irbesartan | NDA | NDA020757 | 150 | mg/1 |
Avapro | irbesartan | Tablet | HUMAN PRESCRIPTION DRUG | 01/01/2013 | 01/01/1900 | Irbesartan | NDA | NDA020757 | 300 | mg/1 |
AVC | sulfanilamide | Cream | HUMAN PRESCRIPTION DRUG | 12/01/2014 | 01/01/1900 | Sulfanilamide | NDA | NDA006530 | 15 | g/100g |
AXIRON | testosterone | Solution | HUMAN PRESCRIPTION DRUG | 12/01/2010 | 01/01/1900 | Testosterone | NDA | NDA022504 | 30 | mg/1.5mL |
AZACTAM | AZTREONAM | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/01/2010 | 01/01/1900 | Aztreonam | NDA | NDA050632 | 1 | g/50mL |
AZACTAM | AZTREONAM | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/01/2010 | 01/01/1900 | Aztreonam | NDA | NDA050632 | 2 | g/50mL |
AZACTAM | AZTREONAM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/01/2010 | 01/01/1900 | Aztreonam | NDA | NDA050580 | 1 | g/1 |
AZACTAM | AZTREONAM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/01/2010 | 01/01/1900 | Aztreonam | NDA | NDA050580 | 2 | g/1 |
AZELEX | azelaic acid | Cream | HUMAN PRESCRIPTION DRUG | 03/21/1996 | 01/01/1900 | Azelaic Acid | NDA | NDA020428 | 0.2 | g/g |
Azulfidine | Sulfasalazine | Tablet | HUMAN PRESCRIPTION DRUG | 06/20/1950 | 01/01/1900 | Sulfasalazine | NDA | NDA007073 | 500 | mg/1 |
Azulfidine | Sulfasalazine | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 06/20/1950 | 01/01/1900 | Sulfasalazine | NDA | NDA007073 | 500 | mg/1 |
Bacitracin | Bacitracin | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 07/29/1948 | 01/01/1900 | Bacitracin A | ANDA | ANDA060733 | 5000 | [USP'U]/mL |
Bacitracin | Bacitracin | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 07/29/1948 | 01/01/1900 | Bacitracin A | ANDA | ANDA060733 | 5000 | [USP'U]/mL |
Bacitracin | Bacitracin | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 07/29/1948 | 01/01/1900 | Bacitracin | ANDA | ANDA060733 | 50000 | [iU]/9.8mL |
Bacitracin | Bacitracin | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 07/29/1948 | 01/01/1900 | Bacitracin A | ANDA | ANDA060733 | 5000 | [USP'U]/mL |
BACTROBAN | mupirocin | Ointment | HUMAN PRESCRIPTION DRUG | 04/07/2000 | 01/01/1900 | Mupirocin | NDA | NDA050591 | 20 | mg/g |
BACTROBAN | mupirocin calcium | Ointment | HUMAN PRESCRIPTION DRUG | 04/10/1996 | 01/01/1900 | Mupirocin Calcium | NDA | NDA050703 | 20 | mg/g |
BACTROBAN | mupirocin calcium | Cream | HUMAN PRESCRIPTION DRUG | 01/23/1998 | 01/01/1900 | Mupirocin Calcium | NDA | NDA050746 | 20 | mg/g |
Balsalazide Disodium | Balsalazide Disodium | Capsule | HUMAN PRESCRIPTION DRUG | 12/28/2007 | 01/01/1900 | Balsalazide Disodium | ANDA | ANDA077806 | 750 | mg/1 |
BARACLUDE | entecavir | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/29/2005 | 01/01/1900 | Entecavir | NDA | NDA021797 | 0.5 | mg/1 |
BARACLUDE | entecavir | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/29/2005 | 01/01/1900 | Entecavir | NDA | NDA021797 | 1 | mg/1 |
BARACLUDE | entecavir | Solution | HUMAN PRESCRIPTION DRUG | 03/29/2005 | 01/01/1900 | Entecavir | NDA | NDA021798 | 0.05 | mg/mL |
BCG VACCINE | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | Injection, Powder, Lyophilized, For Solution | VACCINE | 06/21/1989 | 01/01/1900 | Bacillus Calmette-guerin Substrain Tice Live Antigen | BLA | BLA103050 | 50 | mg/1 |
BELSOMRA | suvorexant | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 08/29/2014 | 01/01/1900 | Suvorexant | NDA | NDA204569 | 5 | mg/1 |
BELSOMRA | suvorexant | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 08/29/2014 | 01/01/1900 | Suvorexant | NDA | NDA204569 | 10 | mg/1 |
BELSOMRA | suvorexant | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 08/29/2014 | 01/01/1900 | Suvorexant | NDA | NDA204569 | 15 | mg/1 |
BELSOMRA | suvorexant | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 08/29/2014 | 01/01/1900 | Suvorexant | NDA | NDA204569 | 20 | mg/1 |
BETAGAN | levobunolol hydrochloride | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 07/24/1986 | 01/01/1900 | Levobunolol Hydrochloride | NDA | NDA019219 | 5 | mg/mL |
BICNU | carmustine | Kit | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 09/30/2015 | NDA | NDA017422 | |||
BiferaRx | Iron Supplement | Tablet | HUMAN PRESCRIPTION DRUG | 10/31/2012 | 01/01/1900 | Cyanocobalamin; Folic Acid; Heme Iron Polypeptide; Iron Dextran | UNAPPROVED DRUG OTHER | 25; 1; 6; 22 | ug/1; mg/1; mg/1; mg/1 | |
BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate | Ointment | HUMAN PRESCRIPTION DRUG | 01/01/1987 | 01/01/1900 | Prednisolone Acetate; Sulfacetamide Sodium | ANDA | ANDA087748 | 2; 100 | mg/g; mg/g |
Boniva | ibandronate sodium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/15/2002 | 01/01/1900 | Ibandronate Sodium | NDA | NDA021455 | 150 | mg/1 |
Boniva | ibandronate sodium | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/01/2011 | 01/01/1900 | Ibandronate Sodium | NDA | NDA021858 | 3 | mg/3mL |
BOTOX | onabotulinumtoxinA | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 12/15/1989 | 01/01/1900 | Botulinum Toxin Type A | BLA | BLA103000 | 100 | [USP'U]/1 |
BOTOX | onabotulinumtoxinA | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/11/2010 | 01/01/1900 | Botulinum Toxin Type A | BLA | BLA103000 | 200 | [USP'U]/1 |
BOTOX Cosmetic | onabotulinumtoxinA | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 07/15/2008 | 01/01/1900 | Botulinum Toxin Type A | BLA | BLA103000 | 50 | [USP'U]/1 |
BOTOX Cosmetic | onabotulinumtoxinA | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/20/2008 | 01/01/1900 | Botulinum Toxin Type A | BLA | BLA103000 | 100 | [USP'U]/1 |
Butisol Sodium | Butabarbital Sodium | Solution | HUMAN PRESCRIPTION DRUG | 06/01/1978 | 06/30/2015 | Butabarbital Sodium | ANDA | ANDA085380 | 30 | mg/5mL |
Butisol Sodium | Butabarbital Sodium | Tablet | HUMAN PRESCRIPTION DRUG | 08/01/1939 | 01/01/1900 | Butabarbital Sodium | NDA | NDA000793 | 30 | mg/1 |
CALAN | verapamil hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/10/1984 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA018817 | 80 | mg/1 |
CALAN | verapamil hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/10/1984 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA018817 | 120 | mg/1 |
CALAN SR | verapamil hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 12/16/1986 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA019152 | 240 | mg/1 |
CALAN SR | verapamil hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 03/06/1991 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA019152 | 120 | mg/1 |
CALAN SR | verapamil hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 12/15/1989 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA019152 | 180 | mg/1 |
Calcitriol | Calcitriol | Capsule | HUMAN PRESCRIPTION DRUG | 03/27/2006 | 01/01/1900 | Calcitriol | ANDA | ANDA076917 | 0.25 | ug/1 |
Calcium Acetate | Calcium Acetate | Capsule | HUMAN PRESCRIPTION DRUG | 02/26/2008 | 01/01/1900 | Calcium Acetate | ANDA | ANDA077728 | 667 | mg/1 |
Camptosar | irinotecan hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/14/1996 | 01/01/1900 | Irinotecan Hydrochloride | NDA | NDA020571 | 20 | mg/mL |
Camptosar | irinotecan hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/14/1996 | 01/01/1900 | Irinotecan Hydrochloride | NDA | NDA020571 | 20 | mg/mL |
CANCIDAS | CASPOFUNGIN ACETATE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/26/2001 | 01/01/1900 | Caspofungin Acetate | NDA | NDA021227 | 5 | mg/mL |
CANCIDAS | CASPOFUNGIN ACETATE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/26/2001 | 01/01/1900 | Caspofungin Acetate | NDA | NDA021227 | 7 | mg/mL |
Cardura | doxazosin mesylate | Tablet, Multilayer, Extended Release | HUMAN PRESCRIPTION DRUG | 02/22/2005 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA021269 | 4 | mg/1 |
Cardura | doxazosin mesylate | Tablet, Multilayer, Extended Release | HUMAN PRESCRIPTION DRUG | 02/22/2005 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA021269 | 8 | mg/1 |
Cardura | doxazosin mesylate | Tablet | HUMAN PRESCRIPTION DRUG | 11/02/1990 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA019668 | 1 | mg/1 |
Cardura | doxazosin mesylate | Tablet | HUMAN PRESCRIPTION DRUG | 11/02/1990 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA019668 | 2 | mg/1 |
Cardura | doxazosin mesylate | Tablet | HUMAN PRESCRIPTION DRUG | 11/02/1990 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA019668 | 4 | mg/1 |
Cardura | doxazosin mesylate | Tablet | HUMAN PRESCRIPTION DRUG | 11/02/1990 | 01/01/1900 | Doxazosin Mesylate | NDA | NDA019668 | 8 | mg/1 |
Caverject | ALPROSTADIL | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 07/06/1995 | 01/01/1900 | Alprostadil | NDA | NDA020379 | 20.5 | ug/mL |
Caverject | ALPROSTADIL | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 07/06/1995 | 01/01/1900 | Alprostadil | NDA | NDA020379 | 10.5 | ug/mL |
Caverject | ALPROSTADIL | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 07/06/1995 | 01/01/1900 | Alprostadil | NDA | NDA020379 | 41.1 | ug/mL |
Caverject | ALPROSTADIL | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 07/06/1995 | 01/01/1900 | Alprostadil | NDA | NDA020379 | 5.4 | ug/mL |
Caverject Impulse | Alprostadil | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/11/2002 | 01/01/1900 | Alprostadil | NDA | NDA021212 | 10 | ug/.5mL |
Caverject Impulse | Alprostadil | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/11/2002 | 01/01/1900 | Alprostadil | NDA | NDA021212 | 20 | ug/.5mL |
CEENU | LOMUSTINE | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 12/15/2008 | 04/15/2016 | Lomustine | NDA | NDA017588 | 10 | mg/1 |
CEENU | LOMUSTINE | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 12/15/2008 | 04/15/2016 | Lomustine | NDA | NDA017588 | 40 | mg/1 |
CELEBREX | Celecoxib | Capsule | HUMAN PRESCRIPTION DRUG | 10/02/1998 | 01/01/1900 | Celecoxib | NDA | NDA020998 | 50 | mg/1 |
CELEBREX | Celecoxib | Capsule | HUMAN PRESCRIPTION DRUG | 10/02/1998 | 01/01/1900 | Celecoxib | NDA | NDA020998 | 100 | mg/1 |
CELEBREX | Celecoxib | Capsule | HUMAN PRESCRIPTION DRUG | 10/02/1998 | 01/01/1900 | Celecoxib | NDA | NDA020998 | 200 | mg/1 |
CELEBREX | Celecoxib | Capsule | HUMAN PRESCRIPTION DRUG | 10/02/1998 | 01/01/1900 | Celecoxib | NDA | NDA020998 | 400 | mg/1 |
CellCept | Mycophenolate Mofetil | Capsule | HUMAN PRESCRIPTION DRUG | 05/03/1995 | 01/01/1900 | Mycophenolate Mofetil | NDA | NDA050722 | 250 | mg/1 |
CellCept | Mycophenolate Mofetil | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/19/1997 | 01/01/1900 | Mycophenolate Mofetil | NDA | NDA050723 | 500 | mg/1 |
CellCept | Mycophenolate Mofetil | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 08/12/1998 | 01/01/1900 | Mycophenolate Mofetil | NDA | NDA050759 | 200 | mg/mL |
CellCept | Mycophenolate Mofetil hydrochloride | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 10/01/1998 | 01/01/1900 | Mycophenolate Mofetil Hydrochloride | NDA | NDA050758 | 500 | mg/20mL |
Cesamet | Nabilone | Capsule | HUMAN PRESCRIPTION DRUG | 03/01/2010 | 01/01/1900 | Nabilone | NDA | NDA018677 | 1 | mg/1 |
CHILDRENS DIMETAPP COLD AND ALLERGY | brompheniramine maleate, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 02/07/2007 | 01/01/1900 | Brompheniramine Maleate; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 1; 2.5 | mg/5mL; mg/5mL |
CHILDRENS DIMETAPP COLD AND ALLERGY | brompheniramine maleate, phenylephrine HCl | Tablet, Chewable | HUMAN OTC DRUG | 09/27/2005 | 01/01/1900 | Brompheniramine Maleate; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 1; 2.5 | mg/1; mg/1 |
CHILDRENS DIMETAPP COLD AND COUGH | brompheniramine maleate, dextromethorphan HBr, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 05/23/2006 | 01/01/1900 | Brompheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 1; 5; 2.5 | mg/5mL; mg/5mL; mg/5mL |
CHILDRENS DIMETAPP LONG ACTING COUGH PLUS COLD | chlorpheniramine maleate, dextromethorphan HBr | Liquid | HUMAN OTC DRUG | 03/04/2005 | 01/01/1900 | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 1; 7.5 | mg/mL; mg/5mL |
Childrens Dimetapp Multi-Symptom Cold and Flu | acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride | Liquid | HUMAN OTC DRUG | 07/01/2014 | 01/01/1900 | Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 320; 12.5; 5 | mg/10mL; mg/10mL; mg/10mL |
CHILDRENS DIMETAPP MULTISYMPTOM COLD AND FLU | acetaminophen, chlorpheniramine maleate, dextromethorphan HBr, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 10/04/2010 | 01/01/1900 | Acetaminophen; Chlorpheniramine Maleate; Dextromethorphan Hydrobromide; Phenylephrine Hydr | OTC MONOGRAPH NOT FINAL | part343 | 160; 1; 5; 2.5 | mg/5mL; mg/5mL; mg/5mL; mg/5mL |
CHILDRENS DIMETAPP NIGHTTIME COLD AND CONGESTION | diphenhydramine HCl, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 11/01/2007 | 01/01/1900 | Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 6.25; 2.5 | mg/5mL; mg/5mL |
Childrens Robitussin Cough and Chest Congestion DM | dextromethorphan hydrobromide, guaifenesin | Liquid | HUMAN OTC DRUG | 07/01/2014 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 5; 100 | mg/5mL; mg/5mL |
Childrens Robitussin Cough and Cold CF | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE | Liquid | HUMAN OTC DRUG | 09/01/2009 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 5; 50; 2.5 | mg/5mL; mg/5mL; mg/5mL |
CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING | chlorpheniramine maleate, dextrometrorphan HBr | Liquid | HUMAN OTC DRUG | 01/01/2004 | 01/01/1900 | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 1; 7.5 | mg/5mL; mg/5mL |
Childrens Robitussin Cough Long-Acting | DEXTROMETHORPHAN HYDROBROMIDE | Liquid | HUMAN OTC DRUG | 01/01/2004 | 01/01/1900 | Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 7.5 | mg/5mL |
Childrens Robitussin Nighttime Cough Long-Acting DM | chlorpheniramine maleate, dextromethorphan hyrdrobromide | Liquid | HUMAN OTC DRUG | 07/01/2014 | 01/01/1900 | Chlorpheniramine Maleate; Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 2; 15 | mg/10mL; mg/10mL |
Cialis | Tadalafil | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/26/2003 | 01/01/1900 | Tadalafil | NDA | NDA021368 | 5 | mg/1 |
Cialis | Tadalafil | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/26/2003 | 01/01/1900 | Tadalafil | NDA | NDA021368 | 10 | mg/1 |
Cialis | Tadalafil | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/26/2003 | 01/01/1900 | Tadalafil | NDA | NDA021368 | 20 | mg/1 |
Cialis | Tadalafil | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/07/2008 | 01/01/1900 | Tadalafil | NDA | NDA021368 | 2.5 | mg/1 |
Cilostazol | Cilostazol | Tablet | HUMAN PRESCRIPTION DRUG | 05/17/2005 | 01/01/1900 | Cilostazol | ANDA | ANDA077024 | 50 | mg/1 |
Cilostazol | Cilostazol | Tablet | HUMAN PRESCRIPTION DRUG | 01/05/2011 | 01/01/1900 | Cilostazol | ANDA | ANDA077024 | 100 | mg/1 |
Citalopram | Citalopram | Solution | HUMAN PRESCRIPTION DRUG | 05/25/2004 | 01/01/1900 | Citalopram Hydrobromide | ANDA | ANDA065178 | 10 | mg/5mL |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 03/11/1981 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050547 | 500 | mg/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 03/11/1981 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050547 | 1 | g/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 03/11/1981 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050547 | 2 | g/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 03/11/1981 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050547 | 10 | g/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 01/13/1987 | 01/01/1900 | Cefotaxime Sodium | ANDA | ANDA062659 | 1 | g/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 01/13/1987 | 01/01/1900 | Cefotaxime Sodium | ANDA | ANDA062659 | 2 | g/1 |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 05/20/1985 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050596 | 1 | g/50mL |
Claforan | cefotaxime sodium | Injection | HUMAN PRESCRIPTION DRUG | 05/20/1985 | 01/01/1900 | Cefotaxime Sodium | NDA | NDA050596 | 2 | g/50mL |
Clarithromycin | clarithromycin | Tablet, Coated | HUMAN PRESCRIPTION DRUG | 11/22/2004 | 01/01/1900 | Clarithromycin | ANDA | ANDA065178 | 250 | mg/1 |
Clarithromycin | clarithromycin | Tablet, Coated | HUMAN PRESCRIPTION DRUG | 05/25/2004 | 01/01/1900 | Clarithromycin | ANDA | ANDA065178 | 500 | mg/1 |
Cleocin | clindamycin phosphate | Suppository | HUMAN PRESCRIPTION DRUG | 08/13/1999 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050767 | 100 | mg/1 |
Cleocin | clindamycin phosphate | Cream | HUMAN PRESCRIPTION DRUG | 08/11/1992 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050680 | 20 | mg/g |
Cleocin Hydrochloride | clindamycin hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 05/22/1970 | 01/01/1900 | Clindamycin Hydrochloride | NDA | NDA050162 | 300 | mg/1 |
Cleocin Hydrochloride | clindamycin hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 05/22/1970 | 01/01/1900 | Clindamycin Hydrochloride | NDA | NDA050162 | 150 | mg/1 |
Cleocin Hydrochloride | clindamycin hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 05/22/1970 | 01/01/1900 | Clindamycin Hydrochloride | NDA | NDA050162 | 75 | mg/1 |
Cleocin Pediatric | clindamycin palmitate hydrochloride | Granule, For Solution | HUMAN PRESCRIPTION DRUG | 04/17/1986 | 01/01/1900 | Clindamycin Palmitate Hydrochloride | ANDA | ANDA062644 | 75 | mg/5mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/02/1972 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/02/1972 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/10/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/02/1972 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/10/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/02/1972 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/16/1987 | 01/01/1900 | Clindamycin Phosphate | ANDA | ANDA062803 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 08/30/1990 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 12 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 08/30/1990 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 6 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 08/30/1990 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 18 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/16/1987 | 01/01/1900 | Clindamycin Phosphate | ANDA | ANDA062803 | 150 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 09/26/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 18 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 09/26/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 12 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 09/26/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050639 | 6 | mg/mL |
Cleocin Phosphate | clindamycin phosphate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/10/2014 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050441 | 150 | mg/mL |
Cleocin T | clindamycin phosphate | Solution | HUMAN PRESCRIPTION DRUG | 06/20/1980 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050537 | 10 | mg/mL |
Cleocin T | clindamycin phosphate | Lotion | HUMAN PRESCRIPTION DRUG | 05/31/1989 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050600 | 10 | mg/mL |
Cleocin T | clindamycin phosphate | Gel | HUMAN PRESCRIPTION DRUG | 01/07/1987 | 01/01/1900 | Clindamycin Phosphate | NDA | NDA050615 | 10 | mg/g |
Clolar | clofarabine | Injection | HUMAN PRESCRIPTION DRUG | 04/01/2013 | 01/01/1900 | Clofarabine | NDA | NDA021673 | 1 | mg/mL |
Colestid | Colestipol Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 07/19/1994 | 01/01/1900 | Colestipol Hydrochloride | NDA | NDA020222 | 1 | g/1 |
Colestid | Colestipol Hydrochloride | Granule, For Suspension | HUMAN PRESCRIPTION DRUG | 04/04/1977 | 01/01/1900 | Colestipol Hydrochloride | NDA | NDA017563 | 5 | g/5g |
COLYTE | peg-3350 and electrolytes | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 08/05/2014 | 01/01/1900 | Polyethylene Glycol 3350; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium | NDA | NDA018983 | 240; 2.98; 6.72; 5.84; 22.72 | g/4L; g/4L; g/4L; g/4L; g/4L |
COMBIGAN | brimonidine tartrate, timolol maleate | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 11/14/2007 | 01/01/1900 | Brimonidine Tartrate; Timolol Maleate | NDA | NDA021398 | 2; 5 | mg/mL; mg/mL |
COMVAX | Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Va | Injection, Suspension | VACCINE | 10/02/1996 | 01/01/1900 | Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein | BLA | BLA103623 | 7.5; 5 | ug/.5mL; ug/.5mL |
Conray | iothalamate meglumine | Injection | HUMAN PRESCRIPTION DRUG | 10/14/2003 | 01/01/1900 | Iothalamate Meglumine | NDA | NDA013295 | 600 | mg/mL |
Conray 30 | Iothalamate Meglumine | Injection | HUMAN PRESCRIPTION DRUG | 03/26/2012 | 01/01/1900 | Iothalamate Meglumine | NDA | NDA016983 | 300 | mg/mL |
Conray 43 | iothalamate meglumine | Injection | HUMAN PRESCRIPTION DRUG | 10/11/2010 | 01/01/1900 | Iothalamate Meglumine | NDA | NDA013295 | 430 | mg/mL |
Copegus | Ribavirin | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/03/2002 | 01/01/1900 | Ribavirin | NDA | NDA021511 | 200 | mg/1 |
Cordarone | amiodarone hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 12/01/1985 | 01/01/1900 | Amiodarone Hydrochloride | NDA | NDA018972 | 200 | mg/1 |
COREG | carvedilol phosphate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/09/2007 | 01/01/1900 | Carvedilol Phosphate | NDA | NDA022012 | 10 | mg/1 |
COREG | carvedilol phosphate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/06/2007 | 01/01/1900 | Carvedilol Phosphate | NDA | NDA022012 | 20 | mg/1 |
COREG | carvedilol phosphate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/14/2007 | 01/01/1900 | Carvedilol Phosphate | NDA | NDA022012 | 40 | mg/1 |
COREG | carvedilol phosphate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/20/2007 | 01/01/1900 | Carvedilol Phosphate | NDA | NDA022012 | 80 | mg/1 |
COREG | carvedilol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/03/1997 | 01/01/1900 | Carvedilol | NDA | NDA020297 | 3.125 | mg/1 |
COREG | carvedilol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/03/1997 | 01/01/1900 | Carvedilol | NDA | NDA020297 | 6.25 | mg/1 |
COREG | carvedilol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/03/1997 | 01/01/1900 | Carvedilol | NDA | NDA020297 | 12.5 | mg/1 |
COREG | carvedilol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/03/1997 | 01/01/1900 | Carvedilol | NDA | NDA020297 | 25 | mg/1 |
CORTEF | hydrocortisone | Tablet | HUMAN PRESCRIPTION DRUG | 12/15/1952 | 01/01/1900 | Hydrocortisone | NDA | NDA008697 | 5 | mg/1 |
CORTEF | hydrocortisone | Tablet | HUMAN PRESCRIPTION DRUG | 12/15/1952 | 01/01/1900 | Hydrocortisone | NDA | NDA008697 | 10 | mg/1 |
CORTEF | hydrocortisone | Tablet | HUMAN PRESCRIPTION DRUG | 12/15/1952 | 01/01/1900 | Hydrocortisone | NDA | NDA008697 | 20 | mg/1 |
Corvert | IBUTILIDE FUMARATE | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/28/1995 | 01/01/1900 | Ibutilide Fumarate | NDA | NDA020491 | 0.1 | mg/mL |
Corvert | ibutilide fumarate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/28/1995 | 01/01/1900 | Ibutilide Fumarate | NDA | NDA020491 | 0.1 | mg/mL |
Corvert | IBUTILIDE FUMARATE | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/28/1995 | 01/01/1900 | Ibutilide Fumarate | NDA | NDA020491 | 0.1 | mg/mL |
COSOPT | dorzolamide hydrochloride and timolol maleate | Solution | HUMAN PRESCRIPTION DRUG | 04/07/1998 | 01/01/1900 | Dorzolamide Hydrochloride; Timolol Maleate | NDA | NDA020869 | 20; 5 | mg/mL; mg/mL |
COSOPT | DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE | Solution | HUMAN PRESCRIPTION DRUG | 02/01/2012 | 01/01/1900 | Dorzolamide Hydrochloride; Timolol Maleate | NDA | NDA202667 | 20; 5 | mg/mL; mg/mL |
Covera-HS | verapamil hydrochloride | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 02/26/1996 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA020552 | 180 | mg/1 |
Covera-HS | verapamil hydrochloride | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 02/26/1996 | 01/01/1900 | Verapamil Hydrochloride | NDA | NDA020552 | 240 | mg/1 |
COZAAR | losartan potassium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/14/1995 | 01/01/1900 | Losartan Potassium | NDA | NDA020386 | 25 | mg/1 |
COZAAR | losartan potassium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/14/1995 | 01/01/1900 | Losartan Potassium | NDA | NDA020386 | 50 | mg/1 |
COZAAR | losartan potassium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/14/1995 | 01/01/1900 | Losartan Potassium | NDA | NDA020386 | 100 | mg/1 |
Creon | Pancrelipase | Capsule, Delayed Release Pellets | HUMAN PRESCRIPTION DRUG | 03/14/2013 | 01/01/1900 | Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease | NDA | NDA020725 | 180000; 36000; 114000 | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
Creon | Pancrelipase | Capsule, Delayed Release | HUMAN PRESCRIPTION DRUG | 04/30/2009 | 01/01/1900 | Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease | NDA | NDA020725 | 15000; 3000; 9500 | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
Creon | Pancrelipase | Capsule, Delayed Release Pellets | HUMAN PRESCRIPTION DRUG | 04/30/2009 | 01/01/1900 | Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease | NDA | NDA020725 | 30000; 6000; 19000 | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
Creon | Pancrelipase | Capsule, Delayed Release Pellets | HUMAN PRESCRIPTION DRUG | 04/30/2009 | 01/01/1900 | Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease | NDA | NDA020725 | 60000; 12000; 38000 | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
Creon | Pancrelipase | Capsule, Delayed Release Pellets | HUMAN PRESCRIPTION DRUG | 04/30/2009 | 01/01/1900 | Pancrelipase Amylase; Pancrelipase Lipase; Pancrelipase Protease | NDA | NDA020725 | 120000; 24000; 76000 | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
CRIXIVAN | indinavir sulfate | Capsule | HUMAN PRESCRIPTION DRUG | 03/13/1996 | 01/01/1900 | Indinavir Sulfate | NDA | NDA020685 | 200 | mg/1 |
CRIXIVAN | indinavir sulfate | Capsule | HUMAN PRESCRIPTION DRUG | 03/13/1996 | 01/01/1900 | Indinavir Sulfate | NDA | NDA020685 | 400 | mg/1 |
CYCLESSA | desogestrel and ethinyl estradiol | Kit | HUMAN PRESCRIPTION DRUG | 12/20/2000 | 01/01/1900 | NDA | NDA021090 | |||
Cyklokapron | TRANEXAMIC ACID | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/30/1986 | 01/01/1900 | Tranexamic Acid | NDA | NDA019281 | 100 | mg/mL |
Cymbalta | Duloxetine hydrochloride | Capsule, Delayed Release | HUMAN PRESCRIPTION DRUG | 01/15/2010 | 01/01/1900 | Duloxetine Hydrochloride | NDA | NDA021427 | 60 | mg/1 |
Cymbalta | Duloxetine hydrochloride | Capsule, Delayed Release | HUMAN PRESCRIPTION DRUG | 08/24/2004 | 01/01/1900 | Duloxetine Hydrochloride | NDA | NDA021427 | 20 | mg/1 |
Cymbalta | Duloxetine hydrochloride | Capsule, Delayed Release | HUMAN PRESCRIPTION DRUG | 08/24/2004 | 01/01/1900 | Duloxetine Hydrochloride | NDA | NDA021427 | 30 | mg/1 |
CYRAMZA | ramucirumab | Solution | HUMAN PRESCRIPTION DRUG | 04/21/2014 | 01/01/1900 | Ramucirumab | BLA | BLA125477 | 10 | mg/mL |
CYRAMZA | ramucirumab | Solution | HUMAN PRESCRIPTION DRUG | 04/21/2014 | 01/01/1900 | Ramucirumab | BLA | BLA125477 | 10 | mg/mL |
Cysto-Conray II | Iothalamate meglumine | Injection | HUMAN PRESCRIPTION DRUG | 10/08/2010 | 01/01/1900 | Iothalamate Meglumine | NDA | NDA017057 | 172 | mg/mL |
Cytotec | misoprostol | Tablet | HUMAN PRESCRIPTION DRUG | 12/27/1986 | 01/01/1900 | Misoprostol | NDA | NDA019268 | 100 | ug/1 |
Cytotec | misoprostol | Tablet | HUMAN PRESCRIPTION DRUG | 12/27/1986 | 01/01/1900 | Misoprostol | NDA | NDA019268 | 200 | ug/1 |
Cytovene | ganciclovir sodium | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/23/1989 | 01/01/1900 | Ganciclovir Sodium | NDA | NDA019661 | 500 | mg/10mL |
Daypro | OXAPROZIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/29/1992 | 01/01/1900 | Oxaprozin | NDA | NDA018841 | 600 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 01/01/2015 | 01/01/1900 | Torsemide | NDA | NDA020136 | 5 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 01/01/2015 | 01/01/1900 | Torsemide | NDA | NDA020136 | 10 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 02/20/2009 | 01/01/1900 | Torsemide | NDA | NDA020136 | 100 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 02/20/2009 | 01/01/1900 | Torsemide | NDA | NDA020136 | 5 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 02/20/2009 | 01/01/1900 | Torsemide | NDA | NDA020136 | 10 | mg/1 |
Demadex | Torsemide | Tablet | HUMAN PRESCRIPTION DRUG | 02/20/2009 | 01/01/1900 | Torsemide | NDA | NDA020136 | 20 | mg/1 |
Demerol | Meperidine Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 11/10/1942 | 01/01/1900 | Meperidine Hydrochloride | NDA | NDA005010 | 50 | mg/1 |
Demerol | Meperidine Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 04/01/2013 | 01/01/1900 | Meperidine Hydrochloride | NDA | NDA005010 | 50 | mg/1 |
Demerol | Meperidine Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 11/10/1942 | 01/01/1900 | Meperidine Hydrochloride | NDA | NDA005010 | 100 | mg/1 |
Demerol | Meperidine Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 05/21/2012 | 01/01/1900 | Meperidine Hydrochloride | NDA | NDA005010 | 100 | mg/1 |
Depen | Penicillamine | Tablet | HUMAN PRESCRIPTION DRUG | 11/30/1978 | 01/01/1900 | Penicillamine | NDA | NDA019854 | 250 | mg/1 |
Depo-Estradiol | estradiol cypionate | Injection | HUMAN PRESCRIPTION DRUG | 08/15/1979 | 01/01/1900 | Estradiol Cypionate | ANDA | ANDA085470 | 5 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 20 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 40 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 40 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 80 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 80 | mg/mL |
Depo-Medrol | METHYLPREDNISOLONE ACETATE | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 40 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 40 | mg/mL |
Depo-Medrol | METHYLPREDNISOLONE ACETATE | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 80 | mg/mL |
Depo-Medrol | methylprednisolone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/28/1959 | 01/01/1900 | Methylprednisolone Acetate | NDA | NDA011757 | 80 | mg/mL |
Depo-Provera | medroxyprogesterone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 10/29/1992 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA020246 | 150 | mg/mL |
Depo-Provera | medroxyprogesterone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 10/29/1992 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA020246 | 150 | mg/mL |
Depo-Provera | medroxyprogesterone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 11/01/1960 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA012541 | 400 | mg/mL |
Depo-SubQ Provera | medroxyprogesterone acetate | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 05/02/2005 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA021583 | 104 | mg/.65mL |
Depo-Testosterone | testosterone cypionate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/31/2014 | 01/01/1900 | Testosterone Cypionate | ANDA | ANDA085635 | 200 | mg/mL |
Depo-Testosterone | testosterone cypionate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/25/1979 | 01/01/1900 | Testosterone Cypionate | ANDA | ANDA085635 | 200 | mg/mL |
Depo-Testosterone | testosterone cypionate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/25/1979 | 01/01/1900 | Testosterone Cypionate | ANDA | ANDA085635 | 100 | mg/mL |
Depo-Testosterone | testosterone cypionate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2014 | 01/01/1900 | Testosterone Cypionate | ANDA | ANDA085635 | 100 | mg/mL |
Depo-Testosterone | testosterone cypionate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2014 | 01/01/1900 | Testosterone Cypionate | ANDA | ANDA085635 | 200 | mg/mL |
Desogen | desogestrel and ethinyl estradiol | Kit | HUMAN PRESCRIPTION DRUG | 06/10/2010 | 01/01/1900 | NDA | NDA020071 | |||
Detrol | tolterodine tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/25/1998 | 01/01/1900 | Tolterodine Tartrate | NDA | NDA020771 | 1 | mg/1 |
Detrol | tolterodine tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/25/1998 | 01/01/1900 | Tolterodine Tartrate | NDA | NDA020771 | 2 | mg/1 |
Detrol LA | tolterodine tartrate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/22/2000 | 01/01/1900 | Tolterodine Tartrate | NDA | NDA021228 | 2 | mg/1 |
Detrol LA | tolterodine tartrate | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 02/22/2000 | 01/01/1900 | Tolterodine Tartrate | NDA | NDA021228 | 4 | mg/1 |
DiaBeta | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Glyburide | NDA | NDA017532 | 2.5 | mg/1 |
DiaBeta | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Glyburide | NDA | NDA017532 | 5 | mg/1 |
DiaBeta | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Glyburide | NDA | NDA017532 | 1.25 | mg/1 |
DIDREX | benzphetamine hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 10/26/1960 | 01/01/1900 | Benzphetamine Hydrochloride | NDA | NDA012427 | 50 | mg/1 |
Diflucan | fluconazole | Tablet | HUMAN PRESCRIPTION DRUG | 01/29/1990 | 01/01/1900 | Fluconazole | NDA | NDA019949 | 50 | mg/1 |
Diflucan | fluconazole | Tablet | HUMAN PRESCRIPTION DRUG | 01/29/1990 | 01/01/1900 | Fluconazole | NDA | NDA019949 | 100 | mg/1 |
Diflucan | fluconazole | Tablet | HUMAN PRESCRIPTION DRUG | 01/29/1990 | 01/01/1900 | Fluconazole | NDA | NDA019949 | 200 | mg/1 |
Diflucan | fluconazole | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 12/23/1993 | 01/01/1900 | Fluconazole | NDA | NDA020090 | 350 | mg/35mL |
Diflucan | fluconazole | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 12/23/1993 | 01/01/1900 | Fluconazole | NDA | NDA020090 | 1400 | mg/35mL |
Diflucan | fluconazole | Tablet | HUMAN PRESCRIPTION DRUG | 01/29/1990 | 01/01/1900 | Fluconazole | NDA | NDA019949 | 150 | mg/1 |
Digoxin | Digoxin | Solution | HUMAN PRESCRIPTION DRUG | 08/26/2004 | 01/01/1900 | Digoxin | NDA | NDA021648 | 0.05 | mg/mL |
Dipentum | olsalazine sodium | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 05/15/2015 | 01/01/1900 | Olsalazine Sodium | NDA | NDA019715 | 250 | mg/1 |
DRISDOL | Ergocalciferol | Capsule, Liquid Filled | HUMAN PRESCRIPTION DRUG | 11/11/1974 | 01/01/1900 | Ergocalciferol | NDA | NDA003444 | 1.25 | mg/1 |
DROXIA | HYDROXYUREA | Capsule | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Hydroxyurea | NDA | NDA016295 | 200 | mg/1 |
DROXIA | HYDROXYUREA | Capsule | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Hydroxyurea | NDA | NDA016295 | 300 | mg/1 |
DROXIA | HYDROXYUREA | Capsule | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Hydroxyurea | NDA | NDA016295 | 400 | mg/1 |
Duavee | conjugated estrogens/bazedoxifene | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/03/2013 | 01/01/1900 | Bazedoxifene Acetate; Estrogens, Conjugated | NDA | NDA022247 | 20; .45 | mg/1; mg/1 |
DYAZIDE | hydrochlorothiazide and triamterene | Capsule | HUMAN PRESCRIPTION DRUG | 03/30/1994 | 01/01/1900 | Hydrochlorothiazide; Triamterene | NDA | NDA016042 | 25; 37.5 | mg/1; mg/1 |
DYMISTA | Azelastine Hydrochloride and Fluticasone Propionate | Spray, Metered | HUMAN PRESCRIPTION DRUG | 05/01/2012 | 01/01/1900 | Azelastine Hydrochloride; Fluticasone Propionate | NDA | NDA202236 | 137; 50 | ug/1; ug/1 |
EC-Naprosyn | naproxen | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 10/14/1994 | 01/01/1900 | Naproxen | NDA | NDA020067 | 375 | mg/1 |
EC-Naprosyn | naproxen | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 10/14/1994 | 01/01/1900 | Naproxen | NDA | NDA020067 | 500 | mg/1 |
Edluar | Zolpidem Tartrate | Tablet | HUMAN PRESCRIPTION DRUG | 07/24/2009 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA021997 | 10 | mg/1 |
Edluar | Zolpidem Tartrate | Tablet | HUMAN PRESCRIPTION DRUG | 07/24/2009 | 01/01/1900 | Zolpidem Tartrate | NDA | NDA021997 | 5 | mg/1 |
Effexor | VENLAFAXINE HYDROCHLORIDE | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 11/01/1997 | 01/01/1900 | Venlafaxine Hydrochloride | NDA | NDA020699 | 75 | mg/1 |
Effexor | VENLAFAXINE HYDROCHLORIDE | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 11/01/1997 | 01/01/1900 | Venlafaxine Hydrochloride | NDA | NDA020699 | 150 | mg/1 |
Effexor | VENLAFAXINE HYDROCHLORIDE | Capsule, Extended Release | HUMAN PRESCRIPTION DRUG | 11/01/1997 | 01/01/1900 | Venlafaxine Hydrochloride | NDA | NDA020699 | 37.5 | mg/1 |
Effient | Prasugrel hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/01/2012 | 01/01/1900 | Prasugrel Hydrochloride | NDA | NDA022307 | 5 | mg/1 |
Effient | Prasugrel hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/01/2012 | 01/01/1900 | Prasugrel Hydrochloride | NDA | NDA022307 | 10 | mg/1 |
ELESTAT | epinastine hydrochloride | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 01/19/2004 | 01/01/1900 | Epinastine Hydrochloride | NDA | NDA021565 | 0.5 | mg/mL |
ELESTRIN | estradiol gel 0.06% | Gel, Metered | HUMAN PRESCRIPTION DRUG | 06/02/2014 | 01/01/1900 | Estradiol | NDA | NDA021813 | 0.52 | mg/g |
ELESTRIN | estradiol gel 0.06% | Gel, Metered | HUMAN PRESCRIPTION DRUG | 06/02/2014 | 01/01/1900 | Estradiol | NDA | NDA021813 | 0.52 | mg/g |
ELIGARD | leuprolide acetate | Kit | HUMAN PRESCRIPTION DRUG | 01/23/2002 | 01/01/1900 | NDA | NDA021379 | |||
ELIGARD | leuprolide acetate | Kit | HUMAN PRESCRIPTION DRUG | 01/23/2002 | 01/01/1900 | NDA | NDA021731 | |||
ELIGARD | leuprolide acetate | Kit | HUMAN PRESCRIPTION DRUG | 01/23/2002 | 01/01/1900 | NDA | NDA021488 | |||
ELIGARD | leuprolide acetate | Kit | HUMAN PRESCRIPTION DRUG | 01/23/2002 | 01/01/1900 | NDA | NDA021343 | |||
ELIQUIS | apixaban | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/28/2012 | 01/01/1900 | Apixaban | NDA | NDA202155 | 2.5 | mg/1 |
ELIQUIS | apixaban | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/28/2012 | 01/01/1900 | Apixaban | NDA | NDA202155 | 5 | mg/1 |
Elitek | rasburicase | Kit | HUMAN PRESCRIPTION DRUG | 07/12/2002 | 01/01/1900 | BLA | BLA103946 | |||
Elitek | rasburicase | Kit | HUMAN PRESCRIPTION DRUG | 06/01/2006 | 01/01/1900 | BLA | BLA103940 | |||
Ellence | epirubicin hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 09/15/1999 | 01/01/1900 | Epirubicin Hydrochloride | NDA | NDA050778 | 2 | mg/mL |
Ellence | epirubicin hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 09/15/1999 | 01/01/1900 | Epirubicin Hydrochloride | NDA | NDA050778 | 2 | mg/mL |
ELOXATIN | oxaliplatin | Injection, Solution, Concentrate | HUMAN PRESCRIPTION DRUG | 06/02/2006 | 01/01/1900 | Oxaliplatin | NDA | NDA021759 | 5 | mg/mL |
ELOXATIN | oxaliplatin | Injection, Solution, Concentrate | HUMAN PRESCRIPTION DRUG | 06/02/2006 | 01/01/1900 | Oxaliplatin | NDA | NDA021759 | 5 | mg/mL |
Emcyt | estramustine phosphate sodium | Capsule | HUMAN PRESCRIPTION DRUG | 01/01/1992 | 01/01/1900 | Estramustine Phosphate Sodium | NDA | NDA018045 | 140 | mg/1 |
EMEND | aprepitant | Capsule | HUMAN PRESCRIPTION DRUG | 03/26/2003 | 01/01/1900 | Aprepitant | NDA | NDA021549 | 80 | mg/1 |
EMEND | aprepitant | Capsule | HUMAN PRESCRIPTION DRUG | 03/26/2003 | 01/01/1900 | Aprepitant | NDA | NDA021549 | 125 | mg/1 |
EMEND | aprepitant | Capsule | HUMAN PRESCRIPTION DRUG | 03/26/2003 | 01/01/1900 | Aprepitant | NDA | NDA021549 | 40 | mg/1 |
EMEND | aprepitant | Kit | HUMAN PRESCRIPTION DRUG | 03/26/2003 | 01/01/1900 | NDA | NDA021549 | |||
EMEND | FOSAPREPITANT DIMEGLUMINE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/25/2008 | 01/01/1900 | Fosaprepitant Dimeglumine | NDA | NDA022023 | 115 | mg/5mL |
EMEND | FOSAPREPITANT DIMEGLUMINE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/25/2008 | 01/01/1900 | Fosaprepitant Dimeglumine | NDA | NDA022023 | 150 | mg/5mL |
EPIFOAM | pramoxine hydrochloride and hydrocortisone acetate | Aerosol, Foam | HUMAN PRESCRIPTION DRUG | 08/25/2014 | 01/01/1900 | Hydrocortisone Acetate; Pramoxine Hydrochloride | ANDA | ANDA086457 | 100; 100 | mg/10g; mg/10g |
ERAXIS | ANIDULAFUNGIN | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 02/17/2006 | 01/01/1900 | Anidulafungin | NDA | NDA021632 | 50 | mg/15mL |
ERAXIS | ANIDULAFUNGIN | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 02/17/2006 | 01/01/1900 | Anidulafungin | NDA | NDA021632 | 100 | mg/30mL |
Estring | estradiol | Ring | HUMAN PRESCRIPTION DRUG | 04/26/1996 | 01/01/1900 | Estradiol | NDA | NDA020472 | 2 | mg/1 |
ETOPOPHOS | etoposide phosphate | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Etoposide Phosphate | NDA | NDA020457 | 100 | mg/1 |
Evista | Raloxifene hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 01/06/1998 | 01/01/1900 | Raloxifene Hydrochloride | NDA | NDA020815 | 60 | mg/1 |
EVOTAZ | atazanavir and cobicistat | Tablet | HUMAN PRESCRIPTION DRUG | 01/29/2015 | 01/01/1900 | Atazanavir Sulfate; Cobicistat | NDA | NDA206353 | 300; 150 | mg/1; mg/1 |
Exemestane | Exemestane | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/01/2011 | 01/01/1900 | Exemestane | ANDA | ANDA077431 | 25 | mg/1 |
FARXIGA | DAPAGLIFLOZIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/08/2014 | 04/30/2017 | Dapagliflozin Propanediol | NDA | NDA202293 | 5 | mg/1 |
FARXIGA | DAPAGLIFLOZIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/08/2014 | 08/31/2017 | Dapagliflozin Propanediol | NDA | NDA202293 | 10 | mg/1 |
Felbatol | felbamate | Tablet | HUMAN PRESCRIPTION DRUG | 07/29/1993 | 01/01/1900 | Felbamate | NDA | NDA020189 | 400 | mg/1 |
Felbatol | felbamate | Tablet | HUMAN PRESCRIPTION DRUG | 07/29/1993 | 01/01/1900 | Felbamate | NDA | NDA020189 | 600 | mg/1 |
Felbatol | felbamate | Suspension | HUMAN PRESCRIPTION DRUG | 07/29/1993 | 01/01/1900 | Felbamate | NDA | NDA020189 | 600 | mg/5mL |
Ferrlecit | sodium ferric gluconate complex | Injection | HUMAN PRESCRIPTION DRUG | 03/01/2011 | 01/01/1900 | Sodium Ferric Gluconate Complex | NDA | NDA020955 | 12.5 | mg/mL |
Ferrlecit | sodium ferric gluconate complex | Injection | HUMAN PRESCRIPTION DRUG | 07/07/2014 | 01/01/1900 | Sodium Ferric Gluconate Complex | NDA | NDA020955 | 12.5 | mg/mL |
FIBERCON | CALCIUM POLYCARBOPHIL | Tablet | HUMAN OTC DRUG | 01/05/2004 | 01/01/1900 | Calcium Polycarbophil | OTC MONOGRAPH NOT FINAL | part334 | 625 | mg/1 |
Flagyl | metronidazole | Capsule | HUMAN PRESCRIPTION DRUG | 05/03/1995 | 01/01/1900 | Metronidazole | NDA | NDA020334 | 375 | mg/1 |
Flagyl | Metronidazole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/18/1963 | 01/01/1900 | Metronidazole | NDA | NDA012623 | 500 | mg/1 |
Flagyl | Metronidazole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/18/1963 | 01/01/1900 | Metronidazole | NDA | NDA012623 | 250 | mg/1 |
Flagyl ER | Metronidazole | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 11/26/1997 | 01/01/1900 | Metronidazole | NDA | NDA020868 | 750 | mg/1 |
Flavored Colestid | Colestipol Hydrochloride | Granule, For Suspension | HUMAN PRESCRIPTION DRUG | 04/04/1977 | 01/01/1900 | Colestipol Hydrochloride | NDA | NDA017563 | 5 | g/7.5g |
Flecainide Acetate | flecainide acetate | Tablet | HUMAN PRESCRIPTION DRUG | 01/14/2003 | 01/01/1900 | Flecainide Acetate | ANDA | ANDA076278 | 50 | mg/1 |
Flecainide Acetate | flecainide acetate | Tablet | HUMAN PRESCRIPTION DRUG | 01/14/2003 | 01/01/1900 | Flecainide Acetate | ANDA | ANDA076278 | 100 | mg/1 |
Flecainide Acetate | flecainide acetate | Tablet | HUMAN PRESCRIPTION DRUG | 01/14/2003 | 01/01/1900 | Flecainide Acetate | ANDA | ANDA076278 | 150 | mg/1 |
Fluconazole | Fluconazole | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 07/29/2004 | 01/01/1900 | Fluconazole | ANDA | ANDA076246 | 10 | mg/mL |
Fluconazole | Fluconazole | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 07/29/2004 | 01/01/1900 | Fluconazole | ANDA | ANDA076246 | 40 | mg/mL |
FML | fluorometholone | Ointment | HUMAN PRESCRIPTION DRUG | 12/09/1985 | 01/01/1900 | Fluorometholone | NDA | NDA017760 | 1 | mg/g |
Follistim AQ | follitropin | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/24/2004 | 01/01/1900 | Follitropin | NDA | NDA021211 | 650 | [iU]/.78mL |
Follistim AQ | follitropin | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/24/2004 | 01/01/1900 | Follitropin | NDA | NDA021211 | 975 | [iU]/1.17mL |
Follistim AQ | follitropin | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/28/2010 | 01/01/1900 | Follitropin | NDA | NDA021273 | 75 | [iU]/.5mL |
Follistim AQ | follitropin | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/28/2010 | 01/01/1900 | Follitropin | NDA | NDA021273 | 150 | [iU]/.5mL |
Follistim AQ | follitropin | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/24/2004 | 01/01/1900 | Follitropin | NDA | NDA021211 | 350 | [iU]/.42mL |
Forteo | Teriparatide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/01/2008 | 01/01/1900 | Teriparatide | NDA | NDA021318 | 250 | ug/mL |
FOSAMAX | alendronate sodium | Tablet | HUMAN PRESCRIPTION DRUG | 09/29/1995 | 01/01/1900 | Alendronate Sodium | NDA | NDA020560 | 70 | mg/1 |
FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Tablet | HUMAN PRESCRIPTION DRUG | 04/07/2005 | 01/01/1900 | Alendronate Sodium; Cholecalciferol | NDA | NDA021762 | 70; 5600 | mg/1; [iU]/1 |
FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Tablet | HUMAN PRESCRIPTION DRUG | 04/07/2005 | 01/01/1900 | Alendronate Sodium; Cholecalciferol | NDA | NDA021762 | 70; 2800 | mg/1; [iU]/1 |
FUZEON | Enfuvirtide | Kit | HUMAN PRESCRIPTION DRUG | 04/10/2012 | 01/01/1900 | NDA | NDA021481 | |||
GALLIUM CITRATE GA-67 | gallium citrate ga-67 | Injection, Solution | HUMAN PRESCRIPTION DRUG | 02/21/2008 | 01/01/1900 | Gallium Chloride Ga-67 | NDA | NDA018058 | 2 | mCi/mL |
Ganirelix Acetate | Ganirelix Acetate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/29/1999 | 01/01/1900 | Ganirelix Acetate | NDA | NDA021057 | 250 | ug/.5mL |
GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant | Injection, Suspension | VACCINE | 06/08/2006 | 01/01/1900 | Human Papillomavirus Type 11 L1 Capsid Protein Antigen; Human Papillomavirus Type 16 L1 Ca | BLA | BLA125126 | 40; 40; 20; 20 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant | Injection, Suspension | VACCINE | 06/08/2006 | 01/01/1900 | Human Papillomavirus Type 11 L1 Capsid Protein Antigen; Human Papillomavirus Type 16 L1 Ca | BLA | BLA125126 | 40; 40; 20; 20 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
GARDASIL 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | Injection, Suspension | VACCINE | 12/10/2014 | 01/01/1900 | Human Papillomavirus Type 11 L1 Capsid Protein Antigen; Human Papillomavirus Type 16 L1 Ca | BLA | BLA125508 | 40; 60; 40; 20; 20; 20; 20; 20; 30 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
GARDASIL 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | Injection, Suspension | VACCINE | 12/10/2014 | 01/01/1900 | Human Papillomavirus Type 11 L1 Capsid Protein Antigen; Human Papillomavirus Type 16 L1 Ca | BLA | BLA125508 | 40; 60; 40; 20; 20; 20; 20; 20; 30 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
Gastrocrom | cromolyn sodium | Liquid | HUMAN PRESCRIPTION DRUG | 05/01/2015 | 01/01/1900 | Cromolyn Sodium | NDA | NDA020479 | 20 | mg/mL |
Gemzar | Gemcitabine hydrochloride | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/22/1996 | 01/01/1900 | Gemcitabine Hydrochloride | NDA | NDA020509 | 200 | mg/5mL |
Gemzar | Gemcitabine hydrochloride | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/22/1996 | 01/01/1900 | Gemcitabine Hydrochloride | NDA | NDA020509 | 1 | g/25mL |
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
GENOTROPIN | somatropin | Kit | HUMAN PRESCRIPTION DRUG | 12/20/1995 | 01/01/1900 | NDA | NDA020280 | |||
Geodon | ziprasidone mesylate | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 12/23/2003 | 01/01/1900 | Ziprasidone Mesylate | NDA | NDA020919 | 20 | mg/mL |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 02/05/2001 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 20 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 02/05/2001 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 40 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 02/05/2001 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 60 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 02/05/2001 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 80 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 11/01/2013 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 20 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 11/01/2013 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 40 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 11/01/2013 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 60 | mg/1 |
Geodon | ziprasidone hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 11/01/2013 | 01/01/1900 | Ziprasidone Hydrochloride | NDA | NDA020825 | 80 | mg/1 |
Glucagon | glucagon | Kit | HUMAN PRESCRIPTION DRUG | 03/01/1999 | 01/01/1900 | NDA | NDA020928 | |||
Glucotrol | glipizide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 04/26/1994 | 01/01/1900 | Glipizide | NDA | NDA020329 | 5 | mg/1 |
Glucotrol | glipizide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 04/10/1999 | 01/01/1900 | Glipizide | NDA | NDA020329 | 10 | mg/1 |
Glucotrol | glipizide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 07/15/2013 | 01/01/1900 | Glipizide | NDA | NDA020329 | 2.5 | mg/1 |
Glucotrol | glipizide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 10/01/2013 | 01/01/1900 | Glipizide | NDA | NDA020329 | 5 | mg/1 |
Glucotrol | glipizide | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 05/09/2013 | 01/01/1900 | Glipizide | NDA | NDA020329 | 10 | mg/1 |
Glucotrol | glipizide | Tablet | HUMAN PRESCRIPTION DRUG | 05/08/1984 | 01/01/1900 | Glipizide | NDA | NDA017783 | 5 | mg/1 |
Glucotrol | glipizide | Tablet | HUMAN PRESCRIPTION DRUG | 05/08/1984 | 01/01/1900 | Glipizide | NDA | NDA017783 | 10 | mg/1 |
Glynase | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 03/04/1992 | 01/01/1900 | Glyburide | NDA | NDA020051 | 6 | mg/1 |
Glynase | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 03/04/1992 | 01/01/1900 | Glyburide | NDA | NDA020051 | 3 | mg/1 |
Glynase | glyburide | Tablet | HUMAN PRESCRIPTION DRUG | 03/04/1992 | 01/01/1900 | Glyburide | NDA | NDA020051 | 1.5 | mg/1 |
Glyset | miglitol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/18/1996 | 01/01/1900 | Miglitol | NDA | NDA020682 | 25 | mg/1 |
Glyset | miglitol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/18/1996 | 01/01/1900 | Miglitol | NDA | NDA020682 | 50 | mg/1 |
Glyset | miglitol | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/18/1996 | 01/01/1900 | Miglitol | NDA | NDA020682 | 100 | mg/1 |
GRASTEK | Timothy Grass Pollen Allergen Extract | Tablet | STANDARDIZED ALLERGENIC | 04/11/2014 | 01/01/1900 | Phleum Pratense Pollen | BLA | BLA125473 | 2800 | [BAU]/1 |
Halcion | triazolam | Tablet | HUMAN PRESCRIPTION DRUG | 11/15/1982 | 01/01/1900 | Triazolam | NDA | NDA017892 | 0.25 | mg/1 |
HALOG | Halcinonide | Solution | HUMAN PRESCRIPTION DRUG | 01/01/2009 | 01/01/1900 | Halcinonide | NDA | NDA017823 | 1 | mg/mL |
Helixate FS | Antihemophilic Factor, Recombinant | Kit | PLASMA DERIVATIVE | 08/18/2000 | 01/01/1900 | BLA | BLA103332 | |||
Helixate FS | Antihemophilic Factor, Recombinant | Kit | PLASMA DERIVATIVE | 08/18/2000 | 01/01/1900 | BLA | BLA103332 | |||
Helixate FS | Antihemophilic Factor, Recombinant | Kit | PLASMA DERIVATIVE | 08/18/2000 | 01/01/1900 | BLA | BLA103332 | |||
Helixate FS | Antihemophilic Factor, Recombinant | Kit | PLASMA DERIVATIVE | 01/16/2008 | 01/01/1900 | BLA | BLA103332 | |||
Helixate FS | Antihemophilic Factor, Recombinant | Kit | PLASMA DERIVATIVE | 07/31/2009 | 01/01/1900 | BLA | BLA103332 | |||
Hemabate | carboprost tromethamine | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/09/1979 | 01/01/1900 | Carboprost Tromethamine | NDA | NDA017989 | 250 | ug/mL |
Hexabrix | IOXAGLATE MEGLUMINE and IOXAGLATE SODIUM | Injection | HUMAN PRESCRIPTION DRUG | 07/26/1985 | 01/01/1900 | Ioxaglate Meglumine; Ioxaglate Sodium | NDA | NDA018905 | 393; 196 | mg/mL; mg/mL |
Humalog | Insulin lispro | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 01/16/2008 | 01/01/1900 | Insulin Lispro | NDA | NDA021017 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 02/07/2006 | 01/01/1900 | Insulin Lispro | NDA | NDA021018 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/16/2008 | 01/01/1900 | Insulin Lispro | NDA | NDA020563 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Solution | HUMAN PRESCRIPTION DRUG | 05/26/2015 | 01/01/1900 | Insulin Lispro | NDA | NDA205747 | 200 | [iU]/mL |
Humalog | Insulin lispro | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/24/1996 | 01/01/1900 | Insulin Lispro | NDA | NDA020563 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 12/22/1999 | 01/01/1900 | Insulin Lispro | NDA | NDA021017 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 02/07/2006 | 01/01/1900 | Insulin Lispro | NDA | NDA021018 | 100 | [iU]/mL |
Humalog | Insulin lispro | Injection, Solution | HUMAN PRESCRIPTION DRUG | 02/20/1998 | 01/01/1900 | Insulin Lispro | NDA | NDA020563 | 100 | [iU]/mL |
HUMATROPE | Somatropin | Kit | HUMAN PRESCRIPTION DRUG | 01/27/2006 | 01/01/1900 | NDA | NDA019640 | |||
HUMATROPE | Somatropin | Kit | HUMAN PRESCRIPTION DRUG | 01/27/2006 | 01/01/1900 | NDA | NDA019640 | |||
HUMATROPE | Somatropin | Kit | HUMAN PRESCRIPTION DRUG | 01/27/2006 | 01/01/1900 | NDA | NDA019640 | |||
HUMATROPE | Somatropin | Kit | HUMAN PRESCRIPTION DRUG | 04/01/1987 | 01/01/1900 | NDA | NDA019640 | |||
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 11/07/2013 | 01/01/1900 | Insulin Human | NDA | NDA019717 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 11/07/2013 | 01/01/1900 | Insulin Human | NDA | NDA018781 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/06/1997 | 01/01/1900 | Insulin Human | NDA | NDA018780 | 500 | [iU]/mL |
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 06/26/1989 | 01/01/1900 | Insulin Human | NDA | NDA019717 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 02/01/1999 | 10/31/2015 | Insulin Human | NDA | NDA018781 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 02/01/1999 | 10/31/2015 | Insulin Human | NDA | NDA019717 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Solution | HUMAN OTC DRUG | 06/27/1983 | 01/01/1900 | Insulin Human | NDA | NDA018780 | 100 | [iU]/mL |
Humulin | Insulin human | Injection, Suspension | HUMAN OTC DRUG | 06/27/1983 | 01/01/1900 | Insulin Human | NDA | NDA018781 | 100 | [iU]/mL |
HYCAMTIN | topotecan hydrochloride | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/07/1996 | 01/01/1900 | Topotecan Hydrochloride | NDA | NDA020671 | 4 | mg/4mL |
HYCAMTIN | topotecan hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 09/16/2008 | 01/01/1900 | Topotecan Hydrochloride | NDA | NDA020981 | 0.25 | mg/1 |
HYCAMTIN | topotecan hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 09/16/2008 | 01/01/1900 | Topotecan Hydrochloride | NDA | NDA020981 | 1 | mg/1 |
HYDREA | HYDROXYUREA | Capsule | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Hydroxyurea | NDA | NDA016295 | 500 | mg/1 |
HYZAAR | losartan potassium and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/28/1995 | 01/01/1900 | Hydrochlorothiazide; Losartan Potassium | NDA | NDA020387 | 12.5; 50 | mg/1; mg/1 |
HYZAAR | losartan potassium and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/28/1995 | 01/01/1900 | Hydrochlorothiazide; Losartan Potassium | NDA | NDA020387 | 12.5; 100 | mg/1; mg/1 |
HYZAAR | losartan potassium and hydrochlorothiazide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/28/1995 | 01/01/1900 | Hydrochlorothiazide; Losartan Potassium | NDA | NDA020387 | 25; 100 | mg/1; mg/1 |
Idamycin PFS | idarubicin hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 02/17/1997 | 01/01/1900 | Idarubicin Hydrochloride | NDA | NDA050734 | 1 | mg/mL |
Idamycin PFS | idarubicin hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 02/17/1997 | 01/01/1900 | Idarubicin Hydrochloride | NDA | NDA050734 | 1 | mg/mL |
Idamycin PFS | idarubicin hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 02/17/1997 | 01/01/1900 | Idarubicin Hydrochloride | NDA | NDA050734 | 1 | mg/mL |
IMPLANON | etonogestrel | Implant | HUMAN PRESCRIPTION DRUG | 09/06/2011 | 01/01/1900 | Etonogestrel | NDA | NDA021529 | 68 | mg/1 |
INDIUM IN 111 CHLORIDE | indium in 111 chloride | Solution | HUMAN PRESCRIPTION DRUG | 12/07/2007 | 01/01/1900 | Indium In-111 Chloride | NDA | NDA019841 | 10 | mCi/mL |
Inspra | eplerenone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/27/2002 | 01/01/1900 | Eplerenone | NDA | NDA021437 | 25 | mg/1 |
Inspra | eplerenone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/27/2002 | 01/01/1900 | Eplerenone | NDA | NDA021437 | 50 | mg/1 |
INVANZ | ertapenem sodium | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 11/21/2001 | 01/01/1900 | Ertapenem Sodium | NDA | NDA021337 | 1 | g/1 |
INVANZ | ertapenem sodium | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 11/21/2001 | 01/01/1900 | Ertapenem Sodium | NDA | NDA021337 | 1 | g/1 |
Invirase | saquinavir mesylate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/17/2004 | 01/01/1900 | Saquinavir Mesylate | NDA | NDA021785 | 500 | mg/1 |
Invirase | saquinavir mesylate | Capsule | HUMAN PRESCRIPTION DRUG | 12/06/1995 | 01/01/1900 | Saquinavir Mesylate | NDA | NDA020628 | 200 | mg/1 |
Ipratropium Bromide | Ipratropium Bromide | Spray | HUMAN PRESCRIPTION DRUG | 11/05/2003 | 01/01/1900 | Ipratropium Bromide | ANDA | ANDA076664 | 21 | ug/1 |
Ipratropium Bromide | Ipratropium Bromide | Spray | HUMAN PRESCRIPTION DRUG | 11/15/2003 | 01/01/1900 | Ipratropium Bromide | ANDA | ANDA076598 | 42 | ug/1 |
ISENTRESS | RALTEGRAVIR | Granule, For Suspension | HUMAN PRESCRIPTION DRUG | 12/20/2013 | 01/01/1900 | Raltegravir Potassium | NDA | NDA205786 | 100 | mg/1 |
ISENTRESS | RALTEGRAVIR | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/12/2007 | 01/01/1900 | Raltegravir Potassium | NDA | NDA022145 | 400 | mg/1 |
ISENTRESS | RALTEGRAVIR | Tablet, Chewable | HUMAN PRESCRIPTION DRUG | 12/21/2011 | 01/01/1900 | Raltegravir Potassium | NDA | NDA203045 | 25 | mg/1 |
ISENTRESS | RALTEGRAVIR | Tablet, Chewable | HUMAN PRESCRIPTION DRUG | 12/21/2011 | 01/01/1900 | Raltegravir Potassium | NDA | NDA203045 | 100 | mg/1 |
IXEMPRA | ixabepilone | Kit | HUMAN PRESCRIPTION DRUG | 10/16/2007 | 01/01/1900 | NDA | NDA022065 | |||
IXEMPRA | ixabepilone | Kit | HUMAN PRESCRIPTION DRUG | 10/16/2007 | 01/01/1900 | NDA | NDA022065 | |||
JANUMET | sitagliptin and metformin hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 02/02/2012 | 01/01/1900 | Metformin Hydrochloride; Sitagliptin Phosphate | NDA | NDA202270 | 500; 50 | mg/1; mg/1 |
JANUMET | sitagliptin and metformin hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 02/02/2012 | 01/01/1900 | Metformin Hydrochloride; Sitagliptin Phosphate | NDA | NDA202270 | 1000; 50 | mg/1; mg/1 |
JANUMET | sitagliptin and metformin hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 02/02/2012 | 01/01/1900 | Metformin Hydrochloride; Sitagliptin Phosphate | NDA | NDA202270 | 1000; 100 | mg/1; mg/1 |
JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/30/2007 | 01/01/1900 | Metformin Hydrochloride; Sitagliptin Phosphate | NDA | NDA022044 | 500; 50 | mg/1; mg/1 |
JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/30/2007 | 01/01/1900 | Metformin Hydrochloride; Sitagliptin Phosphate | NDA | NDA022044 | 1000; 50 | mg/1; mg/1 |
JANUVIA | sitagliptin | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/16/2006 | 01/01/1900 | Sitagliptin Phosphate | NDA | NDA021995 | 25 | mg/1 |
JANUVIA | sitagliptin | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/16/2006 | 01/01/1900 | Sitagliptin Phosphate | NDA | NDA021995 | 50 | mg/1 |
JANUVIA | sitagliptin | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/16/2006 | 01/01/1900 | Sitagliptin Phosphate | NDA | NDA021995 | 100 | mg/1 |
Jevtana | cabazitaxel | Kit | HUMAN PRESCRIPTION DRUG | 06/17/2010 | 01/01/1900 | NDA | NDA201023 | |||
KENALOG-10 | TRIAMCINOLONE ACETONIDE | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Triamcinolone Acetonide | NDA | NDA012041 | 10 | mg/mL |
KENALOG-40 | TRIAMCINOLONE ACETONIDE | Injection, Suspension | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Triamcinolone Acetonide | NDA | NDA014901 | 40 | mg/mL |
KEYTRUDA | pembrolizumab | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/15/2015 | 01/01/1900 | Pembrolizumab | BLA | BLA125514 | 25 | mg/mL |
KEYTRUDA | pembrolizumab | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 09/04/2014 | 01/01/1900 | Pembrolizumab | BLA | BLA125514 | 50 | mg/2mL |
KIT FOR THE PREPARATION OF TC 99M PYROPHOSPHATE | TechneScan PYP | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 03/20/2009 | 01/01/1900 | Sodium Pyrophosphate; Stannous Chloride | NDA | NDA017538 | 11.9; 3.2 | mg/10mL; mg/10mL |
Kit for the Preparation of Technetium Tc 99m Sestamibi | Tc 99m Sestamibi | Injection | HUMAN PRESCRIPTION DRUG | 10/31/2011 | 01/01/1900 | Tetrakis(2-methoxyisobutylisocyanide)copper(i) Tetrafluoroborate | ANDA | ANDA078098 | 1 | mg/10mL |
Klonopin | Clonazepam | Tablet | HUMAN PRESCRIPTION DRUG | 06/02/1975 | 01/01/1900 | Clonazepam | NDA | NDA017533 | 2 | mg/1 |
Klonopin | Clonazepam | Tablet | HUMAN PRESCRIPTION DRUG | 06/02/1975 | 01/01/1900 | Clonazepam | NDA | NDA017533 | 1 | mg/1 |
Klonopin | Clonazepam | Tablet | HUMAN PRESCRIPTION DRUG | 06/02/1975 | 01/01/1900 | Clonazepam | NDA | NDA017533 | 0.5 | mg/1 |
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2000 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2013 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2000 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2013 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2000 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2013 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/07/2007 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2013 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 07/31/2009 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 06/26/2013 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 11/17/2005 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 11/17/2005 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 11/17/2005 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 07/04/2008 | 01/01/1900 | BLA | BLA103332 | |||
Kogenate FS | Antihemophilic Factor (Recombinant) | Kit | PLASMA DERIVATIVE | 07/31/2009 | 01/01/1900 | BLA | BLA103332 | |||
KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 11/05/2010 | 04/30/2017 | Metformin Hydrochloride; Saxagliptin Hydrochloride | NDA | NDA200678 | 500; 5 | mg/1; mg/1 |
KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 11/05/2010 | 05/31/2017 | Metformin Hydrochloride; Saxagliptin Hydrochloride | NDA | NDA200678 | 1000; 2.5 | mg/1; mg/1 |
KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 11/05/2010 | 03/31/2017 | Metformin Hydrochloride; Saxagliptin Hydrochloride | NDA | NDA200678 | 1000; 5 | mg/1; mg/1 |
Lasix | furosemide | Tablet | HUMAN PRESCRIPTION DRUG | 07/01/1966 | 01/01/1900 | Furosemide | NDA | NDA016273 | 40 | mg/1 |
Lasix | furosemide | Tablet | HUMAN PRESCRIPTION DRUG | 07/01/1966 | 01/01/1900 | Furosemide | NDA | NDA016273 | 80 | mg/1 |
Lasix | furosemide | Tablet | HUMAN PRESCRIPTION DRUG | 07/01/1966 | 01/01/1900 | Furosemide | NDA | NDA016273 | 20 | mg/1 |
LASTACAFT | alcaftadine | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 11/01/2010 | 01/01/1900 | Alcaftadine | NDA | NDA022134 | 2.5 | mg/mL |
LATISSE | bimatoprost | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 01/26/2009 | 01/01/1900 | Bimatoprost | NDA | NDA022369 | 0.3 | mg/mL |
Leukine | SARGRAMOSTIM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 05/01/1991 | 01/01/1900 | Sargramostim | BLA | BLA103362 | 250 | ug/mL |
Leukine | SARGRAMOSTIM | Liquid | HUMAN PRESCRIPTION DRUG | 12/01/1996 | 01/01/1900 | Sargramostim | BLA | BLA103362 | 500 | ug/mL |
Lincocin | lincomycin hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/29/1964 | 01/01/1900 | Lincomycin Hydrochloride | NDA | NDA050317 | 300 | mg/mL |
Lithium Carbonate | Lithium Carbonate | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 01/05/2004 | 01/01/1900 | Lithium Carbonate | ANDA | ANDA076691 | 450 | mg/1 |
Lithium Carbonate | Lithium Carbonate | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 10/28/2004 | 01/01/1900 | Lithium Carbonate | ANDA | ANDA076832 | 300 | mg/1 |
Livalo | pitavastatin calcium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 05/15/2010 | 01/01/1900 | Pitavastatin Calcium | NDA | NDA022363 | 1 | mg/1 |
Livalo | pitavastatin calcium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 05/15/2010 | 01/01/1900 | Pitavastatin Calcium | NDA | NDA022363 | 2 | mg/1 |
Livalo | pitavastatin calcium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 05/15/2010 | 01/01/1900 | Pitavastatin Calcium | NDA | NDA022363 | 4 | mg/1 |
Lomotil | diphenoxylate hydrochloride and atropine sulfate | Tablet | HUMAN PRESCRIPTION DRUG | 09/15/1960 | 01/01/1900 | Atropine Sulfate; Diphenoxylate Hydrochloride | NDA | NDA012462 | .025; 2.5 | mg/1; mg/1 |
Lufyllin | Dyphylline | Tablet | HUMAN PRESCRIPTION DRUG | 08/31/1976 | 02/29/2016 | Dyphylline | ANDA | ANDA084566 | 200 | mg/1 |
LUMIGAN | bimatoprost | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 09/10/2010 | 01/01/1900 | Bimatoprost | NDA | NDA022184 | 0.1 | mg/mL |
LYSODREN | MITOTANE | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Mitotane | NDA | NDA016885 | 500 | mg/1 |
M-M-R II | measles, mumps, and rubella virus vaccine live | Injection, Powder, Lyophilized, For Suspension | VACCINE | 04/21/1971 | 01/01/1900 | Measles Virus Strain Enders' Attenuated Edmonston Live Antigen; Mumps Virus Strain B Level | BLA | BLA101069 | 1000; 12500; 1000 | [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL |
Marinol | Dronabinol | Capsule | HUMAN PRESCRIPTION DRUG | 07/13/2010 | 01/01/1900 | Dronabinol | NDA | NDA018651 | 2.5 | mg/1 |
Marinol | Dronabinol | Capsule | HUMAN PRESCRIPTION DRUG | 07/13/2010 | 01/01/1900 | Dronabinol | NDA | NDA018651 | 5 | mg/1 |
Marinol | Dronabinol | Capsule | HUMAN PRESCRIPTION DRUG | 07/13/2010 | 01/01/1900 | Dronabinol | NDA | NDA018651 | 10 | mg/1 |
MAXALT | rizatriptan benzoate | Tablet | HUMAN PRESCRIPTION DRUG | 06/29/1998 | 01/01/1900 | Rizatriptan Benzoate | NDA | NDA020864 | 5 | mg/1 |
MAXALT | rizatriptan benzoate | Tablet | HUMAN PRESCRIPTION DRUG | 06/29/1998 | 01/01/1900 | Rizatriptan Benzoate | NDA | NDA020864 | 10 | mg/1 |
MAXALT-MLT | rizatriptan benzoate | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 06/29/1998 | 01/01/1900 | Rizatriptan Benzoate | NDA | NDA020865 | 5 | mg/1 |
MAXALT-MLT | rizatriptan benzoate | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 06/29/1998 | 01/01/1900 | Rizatriptan Benzoate | NDA | NDA020865 | 10 | mg/1 |
MD-76R | Diatrizoate meglumine and Diatrizoate sodium | Solution | HUMAN PRESCRIPTION DRUG | 09/29/1989 | 01/01/1900 | Diatrizoate Meglumine; Diatrizoate Sodium | NDA | NDA019292 | 660; 100 | mg/mL; mg/mL |
MD-GASTROVIEW | diatrizoate meglumine and diatrizoate sodium | Solution | HUMAN PRESCRIPTION DRUG | 08/31/2009 | 01/01/1900 | Diatrizoate Meglumine; Diatrizoate Sodium | ANDA | ANDA087388 | 600; 100 | mg/mL; mg/mL |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 09/20/2013 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 2 | mg/1 |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 10/24/1957 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 8 | mg/1 |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 10/24/1957 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 32 | mg/1 |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 10/24/1957 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 16 | mg/1 |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 10/24/1957 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 2 | mg/1 |
Medrol | methylprednisolone | Tablet | HUMAN PRESCRIPTION DRUG | 10/24/1957 | 01/01/1900 | Methylprednisolone | NDA | NDA011153 | 4 | mg/1 |
Mefloquine Hydrochloride | mefloquine hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 10/01/2004 | 01/01/1900 | Mefloquine Hydrochloride | ANDA | ANDA076523 | 250 | mg/1 |
MEGACE | MEGESTROL ACETATE | Suspension | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Megestrol Acetate | NDA | NDA020264 | 40 | mg/mL |
MEVACOR | lovastatin | Tablet | HUMAN PRESCRIPTION DRUG | 08/31/1987 | 01/01/1900 | Lovastatin | NDA | NDA019643 | 20 | mg/1 |
MEVACOR | lovastatin | Tablet | HUMAN PRESCRIPTION DRUG | 08/31/1987 | 01/01/1900 | Lovastatin | NDA | NDA019643 | 40 | mg/1 |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 50 | ug/.3mL |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 75 | ug/.3mL |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 100 | ug/.3mL |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 150 | ug/.3mL |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 200 | ug/.3mL |
Mircera | Methoxy polyethylene glycol-epoetin beta | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/24/2014 | 01/01/1900 | Methoxy Polyethylene Glycol-epoetin Beta | BLA | BLA125164 | 250 | ug/.3mL |
Monoclate-P | ANTIHEMOPHILIC FACTOR HUMAN | Kit | PLASMA DERIVATIVE | 05/30/1990 | 01/01/1900 | BLA | BLA103953 | |||
Monoclate-P | ANTIHEMOPHILIC FACTOR HUMAN | Kit | PLASMA DERIVATIVE | 05/30/1990 | 01/01/1900 | BLA | BLA103953 | |||
Monoclate-P | ANTIHEMOPHILIC FACTOR HUMAN | Kit | PLASMA DERIVATIVE | 05/30/1990 | 01/01/1900 | BLA | BLA103953 | |||
Monoclate-P | ANTIHEMOPHILIC FACTOR HUMAN | Kit | PLASMA DERIVATIVE | 03/04/2004 | 01/01/1900 | BLA | BLA103953 | |||
Mononine | coagulation factor IX human | Kit | PLASMA DERIVATIVE | 08/20/1992 | 01/01/1900 | BLA | BLA103957 | |||
Mononine | coagulation factor IX human | Kit | PLASMA DERIVATIVE | 08/20/1992 | 01/01/1900 | BLA | BLA103957 | |||
Mozobil | PLERIXAFOR | Solution | HUMAN PRESCRIPTION DRUG | 09/01/2013 | 01/01/1900 | Plerixafor | NDA | NDA022311 | 24 | mg/1.2mL |
Multaq | Dronedarone | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/01/2009 | 01/01/1900 | Dronedarone | NDA | NDA022425 | 400 | mg/1 |
MUSE | Alprostadil | Suppository | HUMAN PRESCRIPTION DRUG | 07/22/2011 | 01/01/1900 | Alprostadil | NDA | NDA020700 | 125 | ug/1 |
MUSE | Alprostadil | Suppository | HUMAN PRESCRIPTION DRUG | 07/22/2011 | 01/01/1900 | Alprostadil | NDA | NDA020700 | 250 | ug/1 |
MUSE | Alprostadil | Suppository | HUMAN PRESCRIPTION DRUG | 07/22/2011 | 01/01/1900 | Alprostadil | NDA | NDA020700 | 500 | ug/1 |
MUSE | Alprostadil | Suppository | HUMAN PRESCRIPTION DRUG | 07/22/2011 | 01/01/1900 | Alprostadil | NDA | NDA020700 | 1000 | ug/1 |
Mycobutin | rifabutin | Capsule | HUMAN PRESCRIPTION DRUG | 12/23/1992 | 01/01/1900 | Rifabutin | NDA | NDA050689 | 150 | mg/1 |
Naprosyn | naproxen | Suspension | HUMAN PRESCRIPTION DRUG | 03/23/1987 | 01/01/1900 | Naproxen | NDA | NDA018965 | 125 | mg/5mL |
Naprosyn | naproxen | Tablet | HUMAN PRESCRIPTION DRUG | 03/11/1976 | 01/01/1900 | Naproxen | NDA | NDA017581 | 250 | mg/1 |
Naprosyn | naproxen | Tablet | HUMAN PRESCRIPTION DRUG | 03/11/1976 | 01/01/1900 | Naproxen | NDA | NDA017581 | 375 | mg/1 |
Naprosyn | naproxen | Tablet | HUMAN PRESCRIPTION DRUG | 03/11/1976 | 01/01/1900 | Naproxen | NDA | NDA017581 | 500 | mg/1 |
Natelle One | doconexent, icosapent, calcium, iron, ascorbic acid, pyridoxine, .alpha.-tocopherol, folic | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 02/01/2015 | 01/01/1900 | .alpha.-tocopherol; Ascorbic Acid; Calcium; Doconexent; Folic Acid; Icosapent; Iron; Pyrid | UNAPPROVED DRUG OTHER | 30; 30; 102; 250; 1; .625; 28; 25 | [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 | |
Navane | Thiothixene | Capsule | HUMAN PRESCRIPTION DRUG | 07/24/1967 | 01/01/1900 | Thiothixene | NDA | NDA016584 | 1 | mg/1 |
Navane | Thiothixene | Capsule | HUMAN PRESCRIPTION DRUG | 07/24/1967 | 01/01/1900 | Thiothixene | NDA | NDA016584 | 2 | mg/1 |
Navane | Thiothixene | Capsule | HUMAN PRESCRIPTION DRUG | 07/24/1967 | 01/01/1900 | Thiothixene | NDA | NDA016584 | 5 | mg/1 |
Navane | Thiothixene | Capsule | HUMAN PRESCRIPTION DRUG | 07/24/1967 | 01/01/1900 | Thiothixene | NDA | NDA016584 | 10 | mg/1 |
Navane | Thiothixene | Capsule | HUMAN PRESCRIPTION DRUG | 07/24/1967 | 01/01/1900 | Thiothixene | NDA | NDA016584 | 20 | mg/1 |
Nexplanon | etonogestrel | Implant | HUMAN PRESCRIPTION DRUG | 09/27/2013 | 01/01/1900 | Etonogestrel | NDA | NDA021529 | 68 | mg/1 |
Nexplanon | etonogestrel | Implant | HUMAN PRESCRIPTION DRUG | 07/17/2006 | 01/01/1900 | Etonogestrel | NDA | NDA021529 | 68 | mg/1 |
Nicotrol | nicotine | Inhalant | HUMAN PRESCRIPTION DRUG | 05/02/1997 | 01/01/1900 | Nicotine | NDA | NDA020714 | 4 | mg/1 |
Nicotrol | nicotine | Spray, Metered | HUMAN PRESCRIPTION DRUG | 05/22/1996 | 01/01/1900 | Nicotine | NDA | NDA020385 | 10 | mg/mL |
Norpace | disopyramide phosphate | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 07/20/1982 | 01/01/1900 | Disopyramide Phosphate | NDA | NDA018655 | 100 | mg/1 |
Norpace | disopyramide phosphate | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 07/20/1982 | 01/01/1900 | Disopyramide Phosphate | NDA | NDA018655 | 150 | mg/1 |
Norpace | disopyramide phosphate | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 09/01/1977 | 01/01/1900 | Disopyramide Phosphate | NDA | NDA017447 | 100 | mg/1 |
Norpace | disopyramide phosphate | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 09/01/1977 | 01/01/1900 | Disopyramide Phosphate | NDA | NDA017447 | 150 | mg/1 |
NULOJIX | BELATACEPT | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/15/2011 | 01/01/1900 | Belatacept | BLA | BLA125288 | 250 | mg/1 |
NuvaRing | etonogestrel and ethinyl estradiol | Insert, Extended Release | HUMAN PRESCRIPTION DRUG | 10/03/2001 | 01/01/1900 | Ethinyl Estradiol; Etonogestrel | NDA | NDA021187 | .015; .12 | mg/d; mg/d |
OCTREOSCAN | Indium In -111 Pentetreotide | Kit | HUMAN PRESCRIPTION DRUG | 05/01/2007 | 01/01/1900 | NDA | NDA020314 | |||
Oforta | fludarabine phosphate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/31/2009 | 01/01/1900 | Fludarabine Phosphate | NDA | NDA022273 | 10 | mg/1 |
Ondansetron Hydrochloride | Ondansetron Hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 12/26/2006 | 01/01/1900 | Ondansetron Hydrochloride | ANDA | ANDA076960 | 4 | mg/5mL |
ONGLYZA | SAXAGLIPTIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/31/2009 | 04/30/2017 | Saxagliptin Hydrochloride | NDA | NDA022350 | 2.5 | mg/1 |
ONGLYZA | SAXAGLIPTIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 07/31/2009 | 04/30/2017 | Saxagliptin Hydrochloride | NDA | NDA022350 | 5 | mg/1 |
OPDIVO | nivolumab | Injection | HUMAN PRESCRIPTION DRUG | 12/22/2014 | 01/01/1900 | Nivolumab | BLA | BLA125554 | 10 | mg/mL |
OPDIVO | nivolumab | Injection | HUMAN PRESCRIPTION DRUG | 12/22/2014 | 01/01/1900 | Nivolumab | BLA | BLA125554 | 10 | mg/mL |
OPTIMARK | gadoversetamide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/22/2012 | 01/01/1900 | Gadoversetamide | NDA | NDA020937 | 0.5 | mmol/mL |
OPTIMARK | GADOVERSETAMIDE | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/10/2010 | 01/01/1900 | Gadoversetamide | NDA | NDA020975 | 0.5 | mmol/mL |
OPTIMARK | gadoversetamide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 01/22/2012 | 01/01/1900 | Gadoversetamide | NDA | NDA020976 | 0.5 | mmol/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 10/17/2011 | 01/01/1900 | Ioversol | NDA | NDA020923 | 678 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 03/04/2012 | 01/01/1900 | Ioversol | NDA | NDA019710 | 678 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 03/04/2012 | 01/01/1900 | Ioversol | NDA | NDA019710 | 509 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 10/17/2011 | 01/01/1900 | Ioversol | NDA | NDA020923 | 636 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 03/04/2012 | 01/01/1900 | Ioversol | NDA | NDA019710 | 636 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 10/17/2011 | 01/01/1900 | Ioversol | NDA | NDA020923 | 741 | mg/mL |
Optiray | Ioversol | Injection | HUMAN PRESCRIPTION DRUG | 03/04/2012 | 01/01/1900 | Ioversol | NDA | NDA019710 | 741 | mg/mL |
Optivar | Azelastine Hydrochloride | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 05/22/2000 | 01/01/1900 | Azelastine Hydrochloride | NDA | NDA021127 | 0.5 | mg/mL |
Oral-B | Cetylpyridinium Chloride | Liquid | HUMAN OTC DRUG | 10/15/2005 | 01/01/1900 | Cetylpyridinium Chloride | OTC MONOGRAPH NOT FINAL | part356 | 500 | ug/mL |
Oral-B | Sodium Fluoride | Liquid | HUMAN OTC DRUG | 10/15/2005 | 01/01/1900 | Sodium Fluoride | OTC MONOGRAPH NOT FINAL | part355 | 500 | ug/mL |
Oral-B Fluorinse Mint | Oral-B Fluorinse Mint | Mouthwash | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 2 | mg/mL | |
Oral-B Minute-Foam Banana Splitz | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 10 | mg/g | |
Oral-B Minute-Foam Bubble Gum | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 10 | mg/g | |
Oral-B Minute-Foam Grape Punch | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 10 | mg/g | |
Oral-B Minute-Foam Mellow Mint | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 10 | mg/g | |
Oral-B Minute-Foam Orang-A-Tangy | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Hydrofluoric Acid; Sodium Fluoride | UNAPPROVED DRUG OTHER | 2.3; 10 | mg/g; mg/g | |
Oral-B Minute-Foam Strawberry | Acidulated Phosphate Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 10 | mg/g | |
Oral-B Neutra-Foam Mint | Neutral Sodium Fluoride | Aerosol | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 9 | mg/g | |
Oral-B NeutraCare Mint | Neutral Sodium Fluoride | Gel | HUMAN PRESCRIPTION DRUG | 05/04/2000 | 01/01/1900 | Sodium Fluoride | UNAPPROVED DRUG OTHER | 11 | mg/g | |
ORENCIA | abatacept | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 01/01/2009 | 01/01/1900 | Abatacept | BLA | BLA125118 | 250 | mg/15mL |
ORENCIA | abatacept | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/29/2011 | 01/01/1900 | Abatacept | BLA | BLA125118 | 125 | mg/mL |
Oxcarbazepine | Oxcarbazepine | Tablet | HUMAN PRESCRIPTION DRUG | 10/09/2007 | 01/01/1900 | Oxcarbazepine | ANDA | ANDA077795 | 150 | mg/1 |
Oxcarbazepine | Oxcarbazepine | Tablet | HUMAN PRESCRIPTION DRUG | 10/09/2007 | 01/01/1900 | Oxcarbazepine | ANDA | ANDA077795 | 300 | mg/1 |
Oxcarbazepine | Oxcarbazepine | Tablet | HUMAN PRESCRIPTION DRUG | 10/09/2007 | 01/01/1900 | Oxcarbazepine | ANDA | ANDA077795 | 600 | mg/1 |
OZURDEX | dexamethasone | Implant | HUMAN PRESCRIPTION DRUG | 09/01/2009 | 01/01/1900 | Dexamethasone | NDA | NDA022315 | 0.7 | mg/1 |
Pantoprazole Sodium | pantoprazole sodium | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 01/31/2008 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020987 | 20 | mg/1 |
Pantoprazole Sodium | pantoprazole sodium | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 01/31/2008 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020987 | 40 | mg/1 |
PedvaxHIB | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) | Injection, Suspension | VACCINE | 12/20/1989 | 01/01/1900 | Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein | BLA | BLA103237 | 7.5 | ug/.5mL |
Pegasys | peginterferon alfa-2a | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/16/2002 | 01/01/1900 | Peginterferon Alfa-2a | BLA | BLA103964 | 180 | ug/mL |
Pegasys | peginterferon alfa-2a | Kit | HUMAN PRESCRIPTION DRUG | 10/16/2002 | 07/31/2015 | BLA | BLA103964 | |||
Pegasys | peginterferon alfa-2a | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/29/2011 | 01/01/1900 | Peginterferon Alfa-2a | BLA | BLA103964 | 180 | ug/.5mL |
Pegasys | peginterferon alfa-2a | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/01/2011 | 01/01/1900 | Peginterferon Alfa-2a | BLA | BLA103964 | 135 | ug/.5mL |
Pegasys | peginterferon alfa-2a | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/01/2011 | 01/01/1900 | Peginterferon Alfa-2a | BLA | BLA103964 | 180 | ug/.5mL |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 5000000 | [iU]/1 |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 5000000 | [iU]/1 |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 5000000 | [iU]/1 |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 20000000 | [iU]/1 |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 20000000 | [iU]/1 |
Pfizerpen | penicillin G potassium | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2010 | 01/01/1900 | Penicillin G Potassium | ANDA | ANDA060657 | 20000000 | [iU]/1 |
Phisohex | hexachlorophene | Emulsion | HUMAN PRESCRIPTION DRUG | 06/11/1976 | 01/01/1900 | Hexachlorophene | NDA | NDA006882 | 30 | mg/mL |
Phospholine Iodide | echothiophate iodide | Kit | HUMAN PRESCRIPTION DRUG | 12/04/1959 | 01/01/1900 | NDA | NDA011963 | |||
Pilocarpine Hydrochloride | Pilocarpine Hydrochloride | Tablet | HUMAN PRESCRIPTION DRUG | 12/22/2004 | 03/11/2016 | Pilocarpine Hydrochloride | ANDA | ANDA076963 | 5 | mg/1 |
Plaquenil | Hydroxychloroquine Sulfate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/18/1955 | 01/01/1900 | Hydroxychloroquine Sulfate | NDA | NDA009768 | 200 | mg/1 |
PNEUMOVAX 23 | pneumococcal vaccine polyvalent | Injection, Solution | VACCINE | 07/07/1983 | 01/01/1900 | Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae | BLA | BLA101094 | 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; |
PNEUMOVAX 23 | pneumococcal vaccine polyvalent | Injection, Solution | VACCINE | 07/21/2014 | 01/01/1900 | Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae | BLA | BLA101094 | 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; |
PNEUMOVAX 23 | pneumococcal vaccine polyvalent | Injection, Solution | VACCINE | 07/07/1983 | 01/01/1900 | Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Antigen; Streptococcus Pneumoniae | BLA | BLA101094 | 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25; 25 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; |
Polytrim | polymyxin b sulfate and trimethoprim sulfate | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 01/23/1990 | 01/01/1900 | Polymyxin B Sulfate; Trimethoprim Sulfate | NDA | NDA050567 | 100000; 1 | [USP'U]/mL; mg/mL |
PRAVACHOL | PRAVASTATIN SODIUM | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Pravastatin Sodium | NDA | NDA019898 | 20 | mg/1 |
PRAVACHOL | PRAVASTATIN SODIUM | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Pravastatin Sodium | NDA | NDA019898 | 40 | mg/1 |
PRAVACHOL | PRAVASTATIN SODIUM | Tablet | HUMAN PRESCRIPTION DRUG | 06/01/2009 | 01/01/1900 | Pravastatin Sodium | NDA | NDA019898 | 80 | mg/1 |
PRED-G | gentamicin sulfate and prednisolone acetate | Ointment | HUMAN PRESCRIPTION DRUG | 01/01/1990 | 01/01/1900 | Gentamicin Sulfate; Prednisolone Acetate | NDA | NDA050612 | 3; 6 | mg/g; mg/g |
PRED-G | gentamicin, prednisolone acetate | Suspension/ Drops | HUMAN PRESCRIPTION DRUG | 02/19/1990 | 01/01/1900 | Gentamicin; Prednisolone Acetate | NDA | NDA050586 | 3; 10 | mg/mL; mg/mL |
PredniSONE | PredniSONE | Tablet | HUMAN PRESCRIPTION DRUG | 02/13/2003 | 01/01/1900 | Prednisone | ANDA | ANDA084122 | 10 | mg/1 |
PredniSONE | PredniSONE | Tablet | HUMAN PRESCRIPTION DRUG | 02/13/2003 | 01/01/1900 | Prednisone | ANDA | ANDA087342 | 20 | mg/1 |
PredniSONE | PredniSONE | Tablet | HUMAN PRESCRIPTION DRUG | 03/14/2003 | 01/01/1900 | Prednisone | ANDA | ANDA084283 | 50 | mg/1 |
PreferaOB | Cholecalciferol, .alpha.-tocopherol succinate, d-, thiamine mononitrate, riboflavin, niaci | Tablet, Coated | HUMAN PRESCRIPTION DRUG | 04/28/2015 | 01/01/1900 | .alpha.-tocopherol Succinate, D-; Biotin; Calcium Pantothenate; Cholecalciferol; Cupric Su | UNAPPROVED DRUG OTHER | 10; 30; 10; 400; .8; 12; 1; 6; 28; 17; 250; 50; 1.6; 65; 1.5; 4.5 | [iU]/1; ug/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg | |
PreferaOB ONE | ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine h | Capsule, Liquid Filled | HUMAN PRESCRIPTION DRUG | 04/28/2015 | 01/01/1900 | .alpha.-tocopherol Acetate, Dl-; Ascorbic Acid; Biotin; Calcium Pantothenate; Cholecalcife | UNAPPROVED DRUG OTHER | 10; 25; 30; 10; 400; 12; 1; 6; 22; 17; 175; 50; 200; 15 | [iU]/1; mg/1; ug/1; mg/1; [iU]/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1 | |
PreferaOB plus DHA | prenatal/postnatal multivitamin/multimineral | Kit | HUMAN PRESCRIPTION DRUG | 02/01/2015 | 01/01/1900 | UNAPPROVED DRUG OTHER | ||||
Pregnyl | CHORIOGONADOTROPIN ALFA | Kit | HUMAN PRESCRIPTION DRUG | 10/20/1976 | 01/01/1900 | NDA | NDA017692 | |||
Premarin | estrogens, conjugated | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2006 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA004782 | 0.3 | mg/1 |
Premarin | estrogens, conjugated | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2006 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA004782 | 0.45 | mg/1 |
Premarin | estrogens, conjugated | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2006 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA004782 | 0.625 | mg/1 |
Premarin | estrogens, conjugated | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/01/2006 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA004782 | 0.9 | mg/1 |
Premarin | estrogens, conjugated | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/01/2004 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA004782 | 1.25 | mg/1 |
Premarin | conjugated estrogens | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 12/01/1956 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA010402 | 25 | mg/5mL |
Premarin | conjugated estrogens | Cream | HUMAN PRESCRIPTION DRUG | 11/01/1978 | 01/01/1900 | Estrogens, Conjugated | NDA | NDA020216 | 0.625 | mg/g |
Premphase | conjugated estrogens and medroxyprogesterone acetate | Kit | HUMAN PRESCRIPTION DRUG | 03/01/2012 | 01/01/1900 | NDA | NDA020527 | |||
Prempro | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 09/21/2009 | 01/01/1900 | Estrogens, Conjugated; Medroxyprogesterone Acetate | NDA | NDA020527 | .3; 1.5 | mg/1; mg/1 |
Prempro | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 09/21/2009 | 01/01/1900 | Estrogens, Conjugated; Medroxyprogesterone Acetate | NDA | NDA020527 | .45; 1.5 | mg/1; mg/1 |
Prempro | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 09/21/2009 | 01/01/1900 | Estrogens, Conjugated; Medroxyprogesterone Acetate | NDA | NDA020527 | .625; 2.5 | mg/1; mg/1 |
Prempro | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 12/03/2012 | 01/01/1900 | Estrogens, Conjugated; Medroxyprogesterone Acetate | NDA | NDA020527 | .625; 5 | mg/1; mg/1 |
Prepidil | dinoprostone | Gel | HUMAN PRESCRIPTION DRUG | 12/09/1992 | 01/01/1900 | Dinoprostone | NDA | NDA019617 | 0.5 | mg/3g |
Prevnar | Pneumococcal 7-valent | Injection, Suspension | VACCINE | 03/01/2000 | 01/01/1900 | Streptococcus Pneumoniae Type 14 Capsular Polysaccharide Diphtheria Crm197 Protein Conjuga | BLA | BLA103905 | 2; 2; 2; 2; 2; 4; 2 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
PREVNAR 13 | pneumococcal 13-valent conjugate vaccine | Injection, Suspension | VACCINE | 03/12/2010 | 01/01/1900 | Streptococcus Pneumoniae Type 1 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugat | BLA | BLA125324 | 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2 | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; |
Primaquine Phosphate | Primaquine Phosphate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/15/2011 | 01/01/1900 | Primaquine Phosphate | NDA | NDA008316 | 15 | mg/1 |
PRIMAXIN | imipenem and cilastatin sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 01/08/1987 | 01/01/1900 | Cilastatin Sodium; Imipenem | ANDA | ANDA062756 | 250; 250 | mg/100mL; mg/100mL |
PRIMAXIN | imipenem and cilastatin sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 01/08/1987 | 01/01/1900 | Cilastatin Sodium; Imipenem | ANDA | ANDA062756 | 500; 500 | mg/100mL; mg/100mL |
PRIMAXIN | imipenem and cilastatin sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/26/1985 | 01/01/1900 | Cilastatin Sodium; Imipenem | NDA | NDA050587 | 250; 250 | mg/100mL; mg/100mL |
PRIMAXIN | imipenem and cilastatin sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/26/1985 | 01/01/1900 | Cilastatin Sodium; Imipenem | NDA | NDA050587 | 500; 500 | mg/100mL; mg/100mL |
PRINIVIL | lisinopril | Tablet | HUMAN PRESCRIPTION DRUG | 12/29/1987 | 01/01/1900 | Lisinopril | NDA | NDA019558 | 5 | mg/1 |
PRINIVIL | lisinopril | Tablet | HUMAN PRESCRIPTION DRUG | 12/29/1987 | 01/01/1900 | Lisinopril | NDA | NDA019558 | 20 | mg/1 |
PRINIVIL | lisinopril | Tablet | HUMAN PRESCRIPTION DRUG | 12/29/1987 | 01/01/1900 | Lisinopril | NDA | NDA019558 | 10 | mg/1 |
Pristiq | desvenlafaxine succinate | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 04/01/2015 | 01/01/1900 | Desvenlafaxine Succinate | NDA | NDA021992 | 25 | mg/1 |
Pristiq | desvenlafaxine succinate | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 05/01/2008 | 01/01/1900 | Desvenlafaxine Succinate | NDA | NDA021992 | 50 | mg/1 |
Pristiq | desvenlafaxine succinate | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 05/01/2008 | 01/01/1900 | Desvenlafaxine Succinate | NDA | NDA021992 | 100 | mg/1 |
PROCTOFOAM | pramoxine hydrochloride hydrocortisone acetate | Aerosol, Foam | HUMAN PRESCRIPTION DRUG | 08/15/2014 | 01/01/1900 | Hydrocortisone Acetate; Pramoxine Hydrochloride | ANDA | ANDA086457 | 100; 100 | mg/10g; mg/10g |
PROCTOFOAM | pramoxine hydrochloride | Aerosol, Foam | HUMAN OTC DRUG | 08/18/2014 | 01/01/1900 | Pramoxine Hydrochloride | OTC MONOGRAPH FINAL | part346 | 150 | mg/15g |
PROMACTA | eltrombopag olamine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/24/2008 | 01/01/1900 | Eltrombopag Olamine | NDA | NDA022291 | 25 | mg/1 |
PROMACTA | eltrombopag olamine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/24/2008 | 01/01/1900 | Eltrombopag Olamine | NDA | NDA022291 | 50 | mg/1 |
PROMACTA | eltrombopag olamine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/05/2009 | 01/01/1900 | Eltrombopag Olamine | NDA | NDA022291 | 75 | mg/1 |
PROMACTA | eltrombopag olamine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 01/02/2012 | 01/01/1900 | Eltrombopag Olamine | NDA | NDA022291 | 12.5 | mg/1 |
PROMACTA | eltrombopag olamine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/10/2014 | 01/01/1900 | Eltrombopag Olamine | NDA | NDA022291 | 100 | mg/1 |
Prometrium | Progesterone | Capsule | HUMAN PRESCRIPTION DRUG | 07/30/2010 | 01/01/1900 | Progesterone | NDA | NDA019781 | 100 | mg/1 |
Prometrium | Progesterone | Capsule | HUMAN PRESCRIPTION DRUG | 07/30/2010 | 01/01/1900 | Progesterone | NDA | NDA019781 | 200 | mg/1 |
PROPECIA | finasteride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/19/1997 | 01/01/1900 | Finasteride | NDA | NDA020788 | 1 | mg/1 |
ProQuad | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | Injection, Powder, Lyophilized, For Suspension | VACCINE | 09/06/2005 | 01/01/1900 | Measles Virus Strain Enders' Attenuated Edmonston Live Antigen; Mumps Virus Strain B Level | BLA | BLA125108 | 1000; 20000; 1000; 9772 | [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL; [PFU]/.5mL |
PROSCAR | FINASTERIDE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/19/1992 | 01/01/1900 | Finasteride | NDA | NDA020180 | 5 | mg/1 |
PROSTIN | alprostadil | Injection, Solution | HUMAN PRESCRIPTION DRUG | 10/16/1981 | 01/01/1900 | Alprostadil | NDA | NDA018484 | 500 | ug/mL |
Prostin | dinoprostone | Suppository | HUMAN PRESCRIPTION DRUG | 01/18/1978 | 01/01/1900 | Dinoprostone | NDA | NDA017810 | 20 | mg/1 |
Protonix | PANTOPRAZOLE SODIUM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 03/17/2014 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020988 | 40 | mg/10mL |
Protonix | PANTOPRAZOLE SODIUM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 05/01/2013 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020988 | 40 | mg/10mL |
Protonix | PANTOPRAZOLE SODIUM | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 05/01/2000 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020987 | 40 | mg/1 |
Protonix | PANTOPRAZOLE SODIUM | Tablet, Delayed Release | HUMAN PRESCRIPTION DRUG | 05/01/2000 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020987 | 20 | mg/1 |
Protonix | PANTOPRAZOLE SODIUM | Granule, Delayed Release | HUMAN PRESCRIPTION DRUG | 02/29/2008 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA022020 | 40 | mg/1 |
Protonix | PANTOPRAZOLE SODIUM | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 05/01/2001 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020988 | 40 | mg/10mL |
Protonix | pantoprazole sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 05/01/2001 | 01/01/1900 | Pantoprazole Sodium | NDA | NDA020988 | 40 | mg/10mL |
Provera | medroxyprogesterone acetate | Tablet | HUMAN PRESCRIPTION DRUG | 06/03/1959 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA011839 | 10 | mg/1 |
Provera | medroxyprogesterone acetate | Tablet | HUMAN PRESCRIPTION DRUG | 06/03/1959 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA011839 | 2.5 | mg/1 |
Provera | medroxyprogesterone acetate | Tablet | HUMAN PRESCRIPTION DRUG | 06/03/1959 | 01/01/1900 | Medroxyprogesterone Acetate | NDA | NDA011839 | 5 | mg/1 |
Prozac | Fluoxetine hydrochloride | Capsule, Delayed Release | HUMAN PRESCRIPTION DRUG | 03/16/2001 | 01/01/1900 | Fluoxetine Hydrochloride | NDA | NDA021235 | 90 | mg/1 |
Quinidine Gluconate | Quinidine Gluconate | Solution | HUMAN PRESCRIPTION DRUG | 03/01/1951 | 01/01/1900 | Quinidine Gluconate | NDA | NDA007529 | 80 | mg/mL |
R-Gene | Arginine Hydrochloride | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/15/1976 | 01/01/1900 | Arginine Hydrochloride | NDA | NDA016931 | 10 | g/100mL |
RAGWITEK | Short Ragweed Pollen Allergen Extract | Tablet | STANDARDIZED ALLERGENIC | 04/17/2014 | 01/01/1900 | Ambrosia Artemisiifolia Pollen | BLA | BLA125478 | 12 | [Amb'a'1'U]/1 |
Ramipril | Ramipril | Capsule | HUMAN PRESCRIPTION DRUG | 06/18/2008 | 01/01/1900 | Ramipril | ANDA | ANDA077900 | 1.25 | mg/1 |
Ramipril | Ramipril | Capsule | HUMAN PRESCRIPTION DRUG | 06/18/2008 | 01/01/1900 | Ramipril | ANDA | ANDA077900 | 2.5 | mg/1 |
Ramipril | Ramipril | Capsule | HUMAN PRESCRIPTION DRUG | 06/18/2008 | 01/01/1900 | Ramipril | ANDA | ANDA077900 | 5 | mg/1 |
Rapamune | SIROLIMUS | Solution | HUMAN PRESCRIPTION DRUG | 09/01/1999 | 01/01/1900 | Sirolimus | NDA | NDA021083 | 1 | mg/mL |
Rapamune | SIROLIMUS | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 03/01/2010 | 01/01/1900 | Sirolimus | NDA | NDA021110 | 0.5 | mg/1 |
Rapamune | SIROLIMUS | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 07/01/2001 | 01/01/1900 | Sirolimus | NDA | NDA021110 | 1 | mg/1 |
Rapamune | SIROLIMUS | Tablet, Sugar Coated | HUMAN PRESCRIPTION DRUG | 07/01/2001 | 01/01/1900 | Sirolimus | NDA | NDA021110 | 2 | mg/1 |
RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | Injection, Suspension | VACCINE | 07/23/1986 | 01/01/1900 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen | BLA | BLA101066 | 5 | ug/.5mL |
RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | Injection, Suspension | VACCINE | 07/23/1986 | 01/01/1900 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen | BLA | BLA101066 | 40 | ug/mL |
RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | Injection, Suspension | VACCINE | 07/23/1986 | 01/01/1900 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen | BLA | BLA101066 | 10 | ug/mL |
RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | Injection, Suspension | VACCINE | 07/23/1986 | 01/01/1900 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen | BLA | BLA101066 | 5 | ug/.5mL |
RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | Injection, Suspension | VACCINE | 07/23/1986 | 01/01/1900 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen | BLA | BLA101066 | 10 | ug/mL |
REFRESH CELLUVISC | carboxymethylcellulose sodium | Gel | HUMAN OTC DRUG | 10/04/1989 | 01/01/1900 | Carboxymethylcellulose Sodium | OTC MONOGRAPH FINAL | part349 | 10 | mg/mL |
REFRESH Classic | Polyvinyl Alcohol, Povidone | Solution/ Drops | HUMAN OTC DRUG | 09/12/1985 | 01/01/1900 | Polyvinyl Alcohol; Povidone | OTC MONOGRAPH FINAL | part349 | 14; 6 | mg/mL; mg/mL |
REFRESH LACRI-LUBE | mineral oil, petrolatum | Ointment | HUMAN OTC DRUG | 12/15/1977 | 01/01/1900 | Mineral Oil; Petrolatum | OTC MONOGRAPH FINAL | part349 | 425; 568 | mg/g; mg/g |
REFRESH LIQUIGEL | Carboxymethylcellulose sodium | Gel | HUMAN OTC DRUG | 10/04/2001 | 01/01/1900 | Carboxymethylcellulose Sodium | OTC MONOGRAPH FINAL | part349 | 10 | mg/mL |
REFRESH OPTIVE | carboxymethylcellulose sodium and glycerin | Solution/ Drops | HUMAN OTC DRUG | 09/06/2006 | 01/01/1900 | Carboxymethylcellulose Sodium; Glycerin | OTC MONOGRAPH FINAL | part349 | 5; 9 | mg/mL; mg/mL |
Refresh Optive | Carboxymethylcellulose Sodium, Glycerin | Solution/ Drops | HUMAN OTC DRUG | 08/22/2008 | 01/01/1900 | Carboxymethylcellulose Sodium; Glycerin | OTC MONOGRAPH FINAL | part349 | 5; 9 | mg/mL; mg/mL |
REFRESH OPTIVE Advanced | carboxymethylcellulose sodium, glycerin, and polysorbate 80 | Solution/ Drops | HUMAN OTC DRUG | 11/30/2011 | 01/01/1900 | Carboxymethylcellulose Sodium; Glycerin; Polysorbate 80 | OTC MONOGRAPH FINAL | part349 | 5; 10; 5 | mg/mL; mg/mL; mg/mL |
REFRESH OPTIVE Advanced | carboxymethylcellulose sodium, glycerin, polysorbate 80 | Solution/ Drops | HUMAN OTC DRUG | 01/15/2013 | 01/01/1900 | Carboxymethylcellulose Sodium; Glycerin; Polysorbate 80 | OTC MONOGRAPH FINAL | part349 | 5; 10; 5 | mg/mL; mg/mL; mg/mL |
REFRESH P.M. | mineral oil, petrolatum | Ointment | HUMAN OTC DRUG | 04/23/1990 | 01/01/1900 | Mineral Oil; Petrolatum | OTC MONOGRAPH FINAL | part349 | 425; 573 | mg/g; mg/g |
REFRESH PLUS | carboxymethylcellulose sodium | Solution/ Drops | HUMAN OTC DRUG | 10/09/1996 | 01/01/1900 | Carboxymethylcellulose Sodium | OTC MONOGRAPH FINAL | part349 | 5 | mg/mL |
REFRESH TEARS | carboxymethylcellulose sodium | Solution/ Drops | HUMAN OTC DRUG | 05/16/1997 | 01/01/1900 | Carboxymethylcellulose Sodium | OTC MONOGRAPH FINAL | part349 | 5 | mg/mL |
Relpax | eletriptan hydrobromide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/26/2002 | 01/01/1900 | Eletriptan Hydrobromide | NDA | NDA021016 | 20 | mg/1 |
Relpax | eletriptan hydrobromide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/26/2002 | 01/01/1900 | Eletriptan Hydrobromide | NDA | NDA021016 | 40 | mg/1 |
REMERON | MIRTAZAPINE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/11/1997 | 01/01/1900 | Mirtazapine | NDA | NDA020415 | 45 | mg/1 |
REMERON | MIRTAZAPINE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/14/1996 | 01/01/1900 | Mirtazapine | NDA | NDA020415 | 30 | mg/1 |
REMERON | MIRTAZAPINE | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/14/1996 | 01/01/1900 | Mirtazapine | NDA | NDA020415 | 15 | mg/1 |
REMERONSOLTAB | MIRTAZAPINE | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 01/12/2001 | 01/01/1900 | Mirtazapine | NDA | NDA021208 | 15 | mg/1 |
REMERONSOLTAB | MIRTAZAPINE | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 01/12/2001 | 01/01/1900 | Mirtazapine | NDA | NDA021208 | 30 | mg/1 |
REMERONSOLTAB | MIRTAZAPINE | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 01/12/2001 | 01/01/1900 | Mirtazapine | NDA | NDA021208 | 45 | mg/1 |
REOPRO | abciximab | Injection, Solution | HUMAN PRESCRIPTION DRUG | 12/16/1993 | 01/01/1900 | Abciximab | BLA | BLA103575 | 2 | mg/mL |
REQUIP | ropinirole hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 11/20/2008 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA022008 | 12 | mg/1 |
REQUIP | ropinirole hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 08/03/2009 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA022008 | 6 | mg/1 |
REQUIP | ropinirole hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 06/30/2008 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA022008 | 2 | mg/1 |
REQUIP | ropinirole hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 06/30/2008 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA022008 | 4 | mg/1 |
REQUIP | ropinirole hydrochloride | Tablet, Film Coated, Extended Release | HUMAN PRESCRIPTION DRUG | 06/30/2008 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA022008 | 8 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/10/1997 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 0.25 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/10/1997 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 0.5 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/01/1997 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 1 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/03/1997 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 2 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 10/10/1997 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 5 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 06/19/2001 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 3 | mg/1 |
REQUIP | ropinirole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 09/21/1999 | 01/01/1900 | Ropinirole Hydrochloride | NDA | NDA020658 | 4 | mg/1 |
RESTASIS | cyclosporine | Emulsion | HUMAN PRESCRIPTION DRUG | 04/01/2003 | 01/01/1900 | Cyclosporine | NDA | NDA050790 | 0.5 | mg/mL |
REYATAZ | ATAZANAVIR | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/2003 | 01/01/1900 | Atazanavir Sulfate | NDA | NDA021567 | 300 | mg/1 |
REYATAZ | ATAZANAVIR | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/2003 | 07/31/2015 | Atazanavir Sulfate | NDA | NDA021567 | 100 | mg/1 |
REYATAZ | ATAZANAVIR | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/2003 | 01/01/1900 | Atazanavir Sulfate | NDA | NDA021567 | 150 | mg/1 |
REYATAZ | ATAZANAVIR | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/2003 | 01/01/1900 | Atazanavir Sulfate | NDA | NDA021567 | 200 | mg/1 |
REYATAZ | ATAZANAVIR | Powder | HUMAN PRESCRIPTION DRUG | 12/19/2014 | 01/01/1900 | Atazanavir Sulfate | NDA | NDA206352 | 50 | mg/1 |
Risperidone | Risperidone | Solution | HUMAN PRESCRIPTION DRUG | 07/29/2009 | 01/01/1900 | Risperidone | ANDA | ANDA076904 | 1 | mg/mL |
ROBITUSSIN LINGERING COLD LONG-ACTING COUGH | dextromethorphan HBr | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 15 | mg/5mL |
ROBITUSSIN LINGERING COLD LONG-ACTING COUGHGELS | dextromethorphan hbr | Capsule, Liquid Filled | HUMAN OTC DRUG | 06/06/2011 | 01/01/1900 | Dextromethorphan Hydrobromide | OTC MONOGRAPH FINAL | part341 | 15 | mg/1 |
Robitussin Maximum Strength Cough Plus Chest Congestion DM | dextromethorphan hydrobromide and guaifenesin | Capsule, Liquid Filled | HUMAN OTC DRUG | 05/23/2013 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 10; 200 | mg/1; mg/1 |
Robitussin Maximum Strength Nighttime Cough DM | DEXTROMETHORPHAN HYDROBROMIDE and DOXYLAMINE SUCCINATE | Liquid | HUMAN OTC DRUG | 03/01/2013 | 01/01/1900 | Dextromethorphan Hydrobromide; Doxylamine Succinate | OTC MONOGRAPH FINAL | part341 | 30; 12.5 | mg/10mL; mg/10mL |
Robitussin Medi-Soothers Cough DM | dextromethorphan hydrobromide and menthol | Lozenge | HUMAN OTC DRUG | 09/01/2014 | 01/01/1900 | Dextromethorphan Hydrobromide; Menthol, Unspecified Form | OTC MONOGRAPH FINAL | part341 | 5; 5 | mg/1; mg/1 |
Robitussin Mucus Plus Chest Congestion | Guaifenesin | Liquid | HUMAN OTC DRUG | 07/18/2012 | 01/01/1900 | Guaifenesin | OTC MONOGRAPH FINAL | part341 | 200 | mg/10mL |
ROBITUSSIN NIGHT TIME COUGH AND COLD | diphenhydramine HCl, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 02/09/2006 | 01/01/1900 | Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 6.25; 2.5 | mg/5mL; mg/5mL |
Robitussin Peak Cold Cough Plus Chest Congestion DM | dextromethorphan hydrobromide and guaifenesin | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 10; 100 | mg/5mL; mg/5mL |
ROBITUSSIN PEAK COLD DAYTIME COLD PLUS FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE | Capsule, Liquid Filled | HUMAN OTC DRUG | 04/15/2012 | 01/01/1900 | Acetaminophen; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 10; 5 | mg/1; mg/1; mg/1 |
ROBITUSSIN PEAK COLD MAXIMUM STRENGTH COUGH PLUS CHEST CONGESTION DM | dextromethorphan HBr, guaifenesin | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 10; 200 | mg/5mL; mg/5mL |
ROBITUSSIN PEAK COLD MAXIMUM STRENGTH MULTI-SYMPTOM COLD | dextromethorphan HBr, guaifenesin, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 10; 200; 5 | mg/5mL; mg/5mL; mg/5mL |
Robitussin Peak Cold Multi-Symptom Cold | dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride | Liquid | HUMAN OTC DRUG | 06/12/2011 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 10; 100; 5 | mg/5mL; mg/5mL; mg/5mL |
ROBITUSSIN PEAK COLD NASAL RELIEF | acetaminophen, phenylephrine HCl | Tablet | HUMAN OTC DRUG | 06/06/2011 | 01/01/1900 | Acetaminophen; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 5 | mg/1; mg/1 |
ROBITUSSIN PEAK COLD NIGHTTIME COLD PLUS FLU | Acetaminophen, DEXTROMETHORPHAN HYDROBROMIDE, and DOXYLAMINE SUCCINATE | Capsule, Liquid Filled | HUMAN OTC DRUG | 04/15/2012 | 01/01/1900 | Acetaminophen; Dextromethorphan Hydrobromide; Doxylamine Succinate | OTC MONOGRAPH FINAL | part341 | 325; 15; 6.25 | mg/1; mg/1; mg/1 |
ROBITUSSIN PEAK COLD NIGHTTIME MULTI-SYMPTOM COLD | acetaminophen, diphenhydramine HCl, phenylephrine HCl | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 160; 6.25; 2.5 | mg/5mL; mg/5mL; mg/5mL |
ROBITUSSIN PEAK COLD NIGHTTIME NASAL RELIEF | acetaminophen, chlorpheniramine maleate, phenylephrine HCl | Tablet | HUMAN OTC DRUG | 06/06/2011 | 01/01/1900 | Acetaminophen; Chlorpheniramine Maleate; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 2; 5 | mg/1; mg/1; mg/1 |
Robitussin Peak Cold Sugar-Free Cough Plus Chest Congestion DM | dextromethorphan hydrobromide and guaifenesin | Liquid | HUMAN OTC DRUG | 06/15/2011 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 10; 100 | mg/5mL; mg/5mL |
Robitussin Severe Multi-Symptom Cough Cold Flu | acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride | Liquid | HUMAN OTC DRUG | 05/01/2015 | 01/01/1900 | Acetaminophen; Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 650; 20; 400; 10 | mg/20mL; mg/20mL; mg/20mL; mg/20mL |
ROBITUSSIN TO GO COUGH AND CHEST CONGESTION DM | dextromethorphan HBr, guaifenesin | Liquid | HUMAN OTC DRUG | 07/31/2007 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 2; 20 | mg/mL; mg/mL |
ROBITUSSIN TO GO COUGH AND COLD CF | dextromethorphan HBr, guaifenesin, phenylephrine HCl | Solution | HUMAN OTC DRUG | 01/07/2008 | 01/01/1900 | Dextromethorphan Hydrobromide; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 20; 200; 10 | mg/10mL; mg/10mL; mg/10mL |
Rocephin | ceftriaxone sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 08/13/1993 | 01/01/1900 | Ceftriaxone Sodium | ANDA | ANDA063239 | 500 | mg/1 |
Rocephin | ceftriaxone sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 08/13/1993 | 01/01/1900 | Ceftriaxone Sodium | ANDA | ANDA063239 | 1 | g/1 |
RotaTeq | Rotavirus Vaccine, Live, Oral, Pentavalent | Solution | VACCINE | 02/03/2006 | 01/01/1900 | Human Rotavirus A Type G1p7(5) Strain Wi79 Live Antigen; Human Rotavirus A Type G2p7(5) St | BLA | BLA125122 | 2200000; 2800000; 2200000; 2000000; 2300000 | [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL |
SANCTURA | trospium chloride | Tablet | HUMAN PRESCRIPTION DRUG | 12/01/2007 | 09/19/2015 | Trospium Chloride | NDA | NDA021595 | 20 | mg/1 |
SAPHRIS | Asenapine Maleate | Tablet | HUMAN PRESCRIPTION DRUG | 08/13/2009 | 01/01/1900 | Asenapine Maleate | NDA | NDA022117 | 5 | mg/1 |
SAPHRIS | Asenapine Maleate | Tablet | HUMAN PRESCRIPTION DRUG | 08/13/2009 | 01/01/1900 | Asenapine Maleate | NDA | NDA022117 | 10 | mg/1 |
SAPHRIS | Asenapine Maleate | Tablet | HUMAN PRESCRIPTION DRUG | 06/21/2010 | 01/01/1900 | Asenapine Maleate | NDA | NDA022117 | 5 | mg/1 |
SAPHRIS | Asenapine Maleate | Tablet | HUMAN PRESCRIPTION DRUG | 06/21/2010 | 01/01/1900 | Asenapine Maleate | NDA | NDA022117 | 10 | mg/1 |
SINEMET | carbidopa and levodopa | Tablet | HUMAN PRESCRIPTION DRUG | 05/02/1975 | 01/01/1900 | Carbidopa; Levodopa | NDA | NDA017555 | 10; 100 | mg/1; mg/1 |
SINEMET | carbidopa and levodopa | Tablet | HUMAN PRESCRIPTION DRUG | 05/02/1975 | 01/01/1900 | Carbidopa; Levodopa | NDA | NDA017555 | 25; 100 | mg/1; mg/1 |
SINEMET | carbidopa and levodopa | Tablet | HUMAN PRESCRIPTION DRUG | 05/02/1975 | 01/01/1900 | Carbidopa; Levodopa | NDA | NDA017555 | 25; 250 | mg/1; mg/1 |
SINEMET | carbidopa and levodopa | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 05/30/1991 | 01/01/1900 | Carbidopa; Levodopa | NDA | NDA019856 | 25; 100 | mg/1; mg/1 |
SINEMET | carbidopa and levodopa | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 05/30/1991 | 01/01/1900 | Carbidopa; Levodopa | NDA | NDA019856 | 50; 200 | mg/1; mg/1 |
SINGULAIR | montelukast sodium | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 02/20/1998 | 01/01/1900 | Montelukast Sodium | NDA | NDA020829 | 10 | mg/1 |
SINGULAIR | montelukast sodium | Tablet, Chewable | HUMAN PRESCRIPTION DRUG | 02/20/1998 | 01/01/1900 | Montelukast Sodium | NDA | NDA020830 | 5 | mg/1 |
SINGULAIR | montelukast sodium | Granule | HUMAN PRESCRIPTION DRUG | 07/26/2002 | 01/01/1900 | Montelukast Sodium | NDA | NDA021409 | 4 | mg/1 |
SINGULAIR | montelukast sodium | Tablet, Chewable | HUMAN PRESCRIPTION DRUG | 02/20/1998 | 01/01/1900 | Montelukast Sodium | NDA | NDA020830 | 4 | mg/1 |
SKIN MEDICA Purifying Foaming Wash | salicylic acid | Liquid | HUMAN OTC DRUG | 01/01/2013 | 01/01/1900 | Salicylic Acid | OTC MONOGRAPH FINAL | part333D | 20 | mg/mL |
SkinMedica Acne Treatment | benzoyl peroxide | Lotion | HUMAN OTC DRUG | 01/01/2013 | 01/01/1900 | Benzoyl Peroxide | OTC MONOGRAPH NOT FINAL | part333D | 25 | mg/g |
SkinMedica Daily Physical Defense SPF 30 Sunscreen | Titanium Dioxide, zinc oxide | Cream | HUMAN OTC DRUG | 01/01/2013 | 01/01/1900 | Titanium Dioxide; Zinc Oxide | OTC MONOGRAPH NOT FINAL | part352 | 73; 34 | mg/g; mg/g |
SkinMedica Environmental Defense Sunscreen SPF 50 | Octinoxate, Octisalate, Octocrylene, Oxybenzone, Zinc Oxide | Cream | HUMAN OTC DRUG | 01/01/2013 | 01/01/1900 | Octinoxate; Octisalate; Octocrylene; Oxybenzone; Zinc Oxide | OTC MONOGRAPH NOT FINAL | part352 | 75; 50; 20; 60; 33 | mg/g; mg/g; mg/g; mg/g; mg/g |
SkinMedica Purifying Toner | Salicylic Acid | Liquid | HUMAN OTC DRUG | 01/01/2013 | 10/31/2015 | Salicylic Acid | OTC MONOGRAPH FINAL | part333D | 20 | mg/mL |
SkinMedica TNS Ultimate Daily Moisturizer Sunscreen SPF 20 | octinoxate, zinc oxide | Cream | HUMAN OTC DRUG | 01/01/2013 | 01/01/1900 | Octinoxate; Zinc Oxide | OTC MONOGRAPH NOT FINAL | part352 | 75; 53 | mg/g; mg/g |
SODIUM CHLORIDE | sodium chloride | Injection | HUMAN PRESCRIPTION DRUG | 09/01/2012 | 01/01/1900 | Sodium Chloride | NDA | NDA021569 | 0.9 | mg/mL |
SODIUM IODIDE I 123 | sodium iodide i 123 | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 04/11/2007 | 01/01/1900 | Sodium Iodide I-123 | ANDA | ANDA071909 | 100 | uCi/1 |
SODIUM IODIDE I 123 | sodium iodide i 123 | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 04/11/2007 | 01/01/1900 | Sodium Iodide I-123 | ANDA | ANDA071910 | 200 | uCi/1 |
SODIUM IODIDE I 131 | sodium iodide i 131 | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 01/25/2012 | 01/01/1900 | Sodium Iodide I-131 | NDA | NDA016517 | 1 | mCi/mL |
Sodium Iodide I-131 | sodium iodide, i-131 | Solution | HUMAN PRESCRIPTION DRUG | 08/22/2011 | 01/01/1900 | Sodium Iodide I-131 | NDA | NDA016515 | 5 | mCi/mL |
Sodium Iodide I-131 | sodium iodide, i-131 | Solution | HUMAN PRESCRIPTION DRUG | 08/22/2011 | 01/01/1900 | Sodium Iodide I-131 | NDA | NDA016515 | 25 | mCi/mL |
Solu-Cortef | hydrocortisone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/27/1955 | 01/01/1900 | Hydrocortisone Sodium Succinate | NDA | NDA009866 | 1000 | mg/8mL |
Solu-Cortef | hydrocortisone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/27/1955 | 01/01/1900 | Hydrocortisone Sodium Succinate | NDA | NDA009866 | 100 | mg/2mL |
Solu-Cortef | hydrocortisone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/27/1955 | 01/01/1900 | Hydrocortisone Sodium Succinate | NDA | NDA009866 | 250 | mg/2mL |
Solu-Cortef | hydrocortisone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/27/1955 | 01/01/1900 | Hydrocortisone Sodium Succinate | NDA | NDA009866 | 500 | mg/4mL |
Solu-Cortef | hydrocortisone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/27/1955 | 01/01/1900 | Hydrocortisone Sodium Succinate | NDA | NDA009866 | 100 | mg/2mL |
Solu-Medrol | methylprednisolone sodium succinate | Kit | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | NDA | NDA011856 | |||
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 1 | g/mL |
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 500 | mg/mL |
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 1 | g/mL |
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 500 | mg/mL |
Solu-Medrol | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 125 | mg/mL |
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 125 | mg/mL |
Solu-Medrol | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 40 | mg/mL |
SOLU-MEDROL | methylprednisolone sodium succinate | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/02/1959 | 01/01/1900 | Methylprednisolone Sodium Succinate | NDA | NDA011856 | 40 | mg/mL |
Soma | Carisoprodol | Tablet | HUMAN PRESCRIPTION DRUG | 07/01/1959 | 01/01/1900 | Carisoprodol | NDA | NDA011792 | 350 | mg/1 |
Soma | Carisoprodol | Tablet | HUMAN PRESCRIPTION DRUG | 09/01/2007 | 01/01/1900 | Carisoprodol | NDA | NDA011792 | 250 | mg/1 |
SOMAVERT | pegvisomant | Kit | HUMAN PRESCRIPTION DRUG | 05/25/2003 | 01/01/1900 | NDA | NDA021106 | |||
SOMAVERT | pegvisomant | Kit | HUMAN PRESCRIPTION DRUG | 05/25/2003 | 01/01/1900 | NDA | NDA021106 | |||
SOMAVERT | pegvisomant | Kit | HUMAN PRESCRIPTION DRUG | 05/25/2003 | 01/01/1900 | NDA | NDA021106 | |||
SOMAVERT | pegvisomant | Kit | HUMAN PRESCRIPTION DRUG | 07/31/2014 | 01/01/1900 | NDA | NDA021106 | |||
SOMAVERT | pegvisomant | Kit | HUMAN PRESCRIPTION DRUG | 07/31/2014 | 01/01/1900 | NDA | NDA021106 | |||
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 05/30/2008 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 100 | mg/1 |
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 10/28/2010 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 80 | mg/1 |
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 10/28/2010 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 140 | mg/1 |
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 06/27/2006 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 70 | mg/1 |
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 06/27/2006 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 20 | mg/1 |
SPRYCEL | dasatinib | Tablet | HUMAN PRESCRIPTION DRUG | 06/27/2006 | 01/01/1900 | Dasatinib | NDA | NDA021986 | 50 | mg/1 |
STERILE DILUENT | Sterile Water | Injection | VACCINE | 05/25/2006 | 01/01/1900 | BLA | BLA125123 | |||
Stimate | desmopressin acetate | Spray, Metered | HUMAN PRESCRIPTION DRUG | 09/16/2011 | 01/01/1900 | Desmopressin Acetate | NDA | NDA020355 | 1.5 | mg/mL |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 03/01/2006 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 80 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 03/01/2006 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 100 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/10/2003 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 18 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/10/2003 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 60 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/10/2003 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 10 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/10/2003 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 25 | mg/1 |
Strattera | Atomoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/10/2003 | 01/01/1900 | Atomoxetine Hydrochloride | NDA | NDA021411 | 40 | mg/1 |
Strattera | Atomoxetine hydrochloride | Kit | HUMAN PRESCRIPTION DRUG | 08/31/2014 | 01/01/1900 | NDA | NDA021411 | |||
Strattera | Atomoxetine hydrochloride | Kit | HUMAN PRESCRIPTION DRUG | 08/31/2014 | 01/01/1900 | NDA | NDA021411 | |||
Strattera | Atomoxetine hydrochloride | Kit | HUMAN PRESCRIPTION DRUG | 08/31/2014 | 01/01/1900 | NDA | NDA021411 | |||
STROMECTOL | ivermectin | Tablet | HUMAN PRESCRIPTION DRUG | 11/22/1996 | 01/01/1900 | Ivermectin | NDA | NDA050742 | 3 | mg/1 |
Symbyax | Olanzapine and Fluoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 04/09/2007 | 01/01/1900 | Fluoxetine Hydrochloride; Olanzapine | NDA | NDA021520 | 25; 3 | mg/1; mg/1 |
Symbyax | Olanzapine and Fluoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/19/2004 | 01/01/1900 | Fluoxetine Hydrochloride; Olanzapine | NDA | NDA021520 | 25; 6 | mg/1; mg/1 |
Symbyax | Olanzapine and Fluoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/19/2004 | 01/01/1900 | Fluoxetine Hydrochloride; Olanzapine | NDA | NDA021520 | 25; 12 | mg/1; mg/1 |
Symbyax | Olanzapine and Fluoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/19/2004 | 01/01/1900 | Fluoxetine Hydrochloride; Olanzapine | NDA | NDA021520 | 50; 6 | mg/1; mg/1 |
Symbyax | Olanzapine and Fluoxetine hydrochloride | Capsule | HUMAN PRESCRIPTION DRUG | 01/19/2004 | 01/01/1900 | Fluoxetine Hydrochloride; Olanzapine | NDA | NDA021520 | 50; 12 | mg/1; mg/1 |
Synarel | nafarelin acetate | Spray, Metered | HUMAN PRESCRIPTION DRUG | 02/13/1990 | 01/01/1900 | Nafarelin Acetate | NDA | NDA019886 | 2 | mg/mL |
Tamiflu | oseltamivir phosphate | Capsule | HUMAN PRESCRIPTION DRUG | 10/27/1999 | 01/01/1900 | Oseltamivir Phosphate | NDA | NDA021087 | 75 | mg/1 |
Tamiflu | oseltamivir phosphate | Capsule | HUMAN PRESCRIPTION DRUG | 10/27/1999 | 01/01/1900 | Oseltamivir Phosphate | NDA | NDA021087 | 45 | mg/1 |
Tamiflu | oseltamivir phosphate | Capsule | HUMAN PRESCRIPTION DRUG | 10/27/1999 | 01/01/1900 | Oseltamivir Phosphate | NDA | NDA021087 | 30 | mg/1 |
Tamiflu | Oseltamivir Phosphate | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 08/01/2013 | 01/01/1900 | Oseltamivir Phosphate | NDA | NDA021246 | 6 | mg/mL |
TAZORAC | tazarotene | Gel | HUMAN PRESCRIPTION DRUG | 08/01/1997 | 01/01/1900 | Tazarotene | NDA | NDA020600 | 1 | mg/g |
TAZORAC | tazarotene | Gel | HUMAN PRESCRIPTION DRUG | 08/01/1997 | 01/01/1900 | Tazarotene | NDA | NDA020600 | 0.5 | mg/g |
TAZORAC | tazarotene | Cream | HUMAN PRESCRIPTION DRUG | 11/15/2000 | 01/01/1900 | Tazarotene | NDA | NDA021184 | 0.5 | mg/g |
TAZORAC | tazarotene | Cream | HUMAN PRESCRIPTION DRUG | 11/13/2000 | 01/01/1900 | Tazarotene | NDA | NDA021184 | 1 | mg/g |
TechneScan HDP | Technetium Tc 99m Oxidronate | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 02/27/2007 | 01/01/1900 | Oxidronate Disodium | NDA | NDA018321 | 3.15 | mg/1 |
TechneScan MAG3 | Mertiatide | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/15/1990 | 01/01/1900 | Betiatide | NDA | NDA019882 | 1 | mg/1 |
THALLOUS CHLORIDE Tl 201 | thallous chloride, Tl 201 | Injection, Solution | HUMAN PRESCRIPTION DRUG | 02/29/2012 | 01/01/1900 | Thallous Chloride Tl-201 | NDA | NDA018150 | 1 | mCi/mL |
Theraflu | Acetaminophen, Diphenhydramine HCl, Phenylepherine HCl | Syrup | HUMAN OTC DRUG | 05/04/2007 | 01/01/1900 | Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 12.5; 5 | mg/15mL; mg/15mL; mg/15mL |
Theraflu | Acetaminophen, Dextromethorphan HBr, Phenylepherine HCl | Syrup | HUMAN OTC DRUG | 05/04/2007 | 01/01/1900 | Acetaminophen; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 10; 5 | mg/15mL; mg/15mL; mg/15mL |
Theraflu | Acetaminophen, Guaifenesin | Powder, For Solution | HUMAN OTC DRUG | 06/23/2006 | 01/01/1900 | Acetaminophen; Guaifenesin | OTC MONOGRAPH FINAL | part341 | 1000; 400 | mg/1; mg/1 |
Theraflu | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | Powder, For Solution | HUMAN OTC DRUG | 09/24/2012 | 01/01/1900 | Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 650; 25; 10 | mg/1; mg/1; mg/1 |
Theraflu | ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE | Powder, For Solution | HUMAN OTC DRUG | 09/24/2012 | 01/01/1900 | Acetaminophen; Dextromethorphan Hydrobromide; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 650; 20; 10 | mg/1; mg/1; mg/1 |
Theraflu | Acetaminophen, Diphenhydramine HCl, Phenylepherine HCl | Syrup | HUMAN OTC DRUG | 07/03/2007 | 01/01/1900 | Acetaminophen; Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 12.5; 5 | mg/15mL; mg/15mL; mg/15mL |
Theraflu | Acetaminophen, Guaifenesin and Phenylephrine HCl | Syrup | HUMAN OTC DRUG | 08/06/2005 | 01/01/1900 | Acetaminophen; Guaifenesin; Phenylephrine Hydrochloride | OTC MONOGRAPH FINAL | part341 | 325; 200; 5 | mg/15mL; mg/15mL; mg/15mL |
TICE BCG | BACILLUS CALMETTE-GUERIN | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 08/24/1990 | 01/01/1900 | Bacillus Calmette-guerin Substrain Tice Live Antigen | BLA | BLA102821 | 50 | mg/50mL |
TIMENTIN | ticarcillin disodium and clavulanate potassium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 10/22/1990 | 07/31/2015 | Clavulanate Potassium; Ticarcillin Disodium | NDA | NDA050590 | 1; 30 | mg/mL; mg/mL |
TIMENTIN | ticarcillin disodium and clavulanate potassium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 10/22/1990 | 07/31/2015 | Clavulanate Potassium; Ticarcillin Disodium | NDA | NDA050590 | 1; 30 | mg/mL; mg/mL |
Torisel | temsirolimus | Kit | HUMAN PRESCRIPTION DRUG | 07/01/2007 | 01/01/1900 | NDA | NDA022088 | |||
TORSEMIDE | TORSEMIDE | Tablet | HUMAN PRESCRIPTION DRUG | 03/03/2005 | 01/01/1900 | Torsemide | ANDA | ANDA076943 | 20 | mg/1 |
TOUJEO | insulin glargine | Injection, Solution | HUMAN PRESCRIPTION DRUG | 02/25/2015 | 01/01/1900 | Insulin Glargine | NDA | NDA206538 | 300 | U/mL |
Trecator | ethionamide | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 11/08/2004 | 01/01/1900 | Ethionamide | NDA | NDA013026 | 250 | mg/1 |
Trulicity | Dulaglutide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/07/2014 | 01/01/1900 | Dulaglutide | BLA | BLA125469 | 0.75 | mg/.5mL |
Trulicity | Dulaglutide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 11/07/2014 | 01/01/1900 | Dulaglutide | BLA | BLA125469 | 1.5 | mg/.5mL |
Trumenba | meningococcal group B vaccine | Injection, Suspension | VACCINE | 11/05/2014 | 01/01/1900 | Neisseria Meningitidis Serogroup B Recombinant Lp2086 A05 Protein Variant Antigen; Neisser | BLA | BLA125549 | 60; 60 | ug/.5mL; ug/.5mL |
TRUSOPT | dorzolamide hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 12/09/1994 | 01/01/1900 | Dorzolamide Hydrochloride | NDA | NDA020408 | 20 | mg/mL |
Tygacil | TIGECYCLINE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 06/01/2005 | 01/01/1900 | Tigecycline | NDA | NDA021821 | 50 | mg/5mL |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/16/1996 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 1 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/16/1996 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 1.5 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/16/1996 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 2 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/16/1996 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 2.5 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/16/1996 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 3 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 3.5 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 5 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 6 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 7.5 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 11 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 14 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 16 | Ci/1 |
Ultra-TechneKow | Technetium Tc-99m Generator | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/01/2005 | 01/01/1900 | Molybdenum Mo-99 | NDA | NDA017243 | 19 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 11 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 14 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 16 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 19 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 7.5 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 5 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 6 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 1 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 1.5 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 2 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 2.5 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 3 | Ci/1 |
Ultra-Technekow | Technetium Tc-99m | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/10/2014 | 01/01/1900 | Technetium Tc-99m Sodium Pertechnetate | NDA | NDA017243 | 3.5 | Ci/1 |
UltraTag | Kit for the preparation of Technetium Tc 99m-Labeled Red Blood Cells | Kit | HUMAN PRESCRIPTION DRUG | 06/10/1991 | 01/01/1900 | NDA | NDA019981 | |||
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA050608 | 1; .5 | g/1; g/1 |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA050608 | 2; 1 | g/1; g/1 |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA050608 | 1; .5 | g/1; g/1 |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA050608 | 2; 1 | g/1; g/1 |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA050608 | 100; 50 | mg/mL; mg/mL |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA062901 | 1; .5 | g/1; g/1 |
UNASYN | ampicillin sodium and sulbactam sodium | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 11/22/1991 | 01/01/1900 | Ampicillin Sodium; Sulbactam Sodium | NDA | NDA062901 | 2; 1 | g/1; g/1 |
URELLE | hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, | Tablet | HUMAN PRESCRIPTION DRUG | 01/12/2015 | 01/01/1900 | Hyoscyamine Sulfate; Methenamine; Methylene Blue; Phenyl Salicylate; Sodium Phosphate, Mon | UNAPPROVED DRUG OTHER | .12; 81; 10.8; 32.4; 40.8 | mg/1; mg/1; mg/1; mg/1; mg/1 | |
Uroxatral | alfuzosin hydrochloride | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 06/05/2009 | 01/01/1900 | Alfuzosin Hydrochloride | NDA | NDA021287 | 10 | mg/1 |
Valcyte | valganciclovir hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/29/2001 | 01/01/1900 | Valganciclovir Hydrochloride | NDA | NDA021304 | 450 | mg/1 |
Valcyte | valganciclovir hydrochloride | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 08/28/2009 | 01/01/1900 | Valganciclovir Hydrochloride | NDA | NDA022257 | 50 | mg/mL |
VANIQA | eflornithine hydrochloride | Cream | HUMAN PRESCRIPTION DRUG | 06/01/2013 | 01/01/1900 | Eflornithine Hydrochloride | NDA | NDA021145 | 139 | mg/g |
VAQTA | hepatitis A vaccine, inactivated | Injection, Suspension | VACCINE | 03/29/1996 | 01/01/1900 | Hepatitis A Virus Strain Cr 326f Antigen (formaldehyde Inactivated) | BLA | BLA103606 | 50 | [iU]/mL |
VAQTA | hepatitis A vaccine, inactivated | Injection, Suspension | VACCINE | 03/29/1996 | 01/01/1900 | Hepatitis A Virus Strain Cr 326f Antigen (formaldehyde Inactivated) | BLA | BLA103606 | 25 | [iU]/.5mL |
VAQTA | hepatitis A vaccine, inactivated | Injection, Suspension | VACCINE | 03/29/1996 | 01/01/1900 | Hepatitis A Virus Strain Cr 326f Antigen (formaldehyde Inactivated) | BLA | BLA103606 | 25 | [iU]/.5mL |
VAQTA | hepatitis A vaccine, inactivated | Injection, Suspension | VACCINE | 03/29/1996 | 01/01/1900 | Hepatitis A Virus Strain Cr 326f Antigen (formaldehyde Inactivated) | BLA | BLA103606 | 50 | [iU]/mL |
VARIVAX | Varicella Virus Vaccine Live | Injection, Powder, Lyophilized, For Suspension | VACCINE | 03/17/1995 | 01/01/1900 | Varicella-zoster Virus Strain Oka/merck Live Antigen | BLA | BLA103552 | 1350 | [PFU]/.5mL |
VARIVAX | Varicella Virus Vaccine Live | Injection, Powder, Lyophilized, For Suspension | VACCINE | 03/17/1995 | 01/01/1900 | Varicella-zoster Virus Strain Oka/merck Live Antigen | BLA | BLA103552 | 1350 | [PFU]/.5mL |
VFEND | voriconazole | Powder, For Suspension | HUMAN PRESCRIPTION DRUG | 03/28/2003 | 01/01/1900 | Voriconazole | NDA | NDA021630 | 40 | mg/mL |
VFEND | voriconazole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/28/2003 | 01/01/1900 | Voriconazole | NDA | NDA021266 | 50 | mg/1 |
VFEND | voriconazole | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 03/28/2003 | 01/01/1900 | Voriconazole | NDA | NDA021266 | 200 | mg/1 |
VFEND | VORICONAZOLE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 10/24/2012 | 01/01/1900 | Voriconazole | NDA | NDA021267 | 10 | mg/mL |
VFEND | VORICONAZOLE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/24/2002 | 01/01/1900 | Voriconazole | NDA | NDA021267 | 10 | mg/mL |
VFEND | voriconazole | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 03/28/2003 | 01/01/1900 | Voriconazole | NDA | NDA021267 | 10 | mg/mL |
VFEND | VORICONAZOLE | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 10/24/2012 | 01/01/1900 | Voriconazole | NDA | NDA021267 | 10 | mg/mL |
vinorelbine tartrate | vinorelbine tartrate | Injection, Solution | HUMAN PRESCRIPTION DRUG | 02/13/2008 | 01/01/1900 | Vinorelbine Tartrate | ANDA | ANDA178408 | 10 | mg/mL |
Vistaril | hydroxyzine hydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 09/18/1957 | 01/01/1900 | Hydroxyzine Hydrochloride | NDA | NDA011111 | 50 | mg/mL |
Vivaglobin | Human Immunoglobulin G | Solution | HUMAN PRESCRIPTION DRUG | 01/09/2006 | 01/01/1900 | Human Immunoglobulin G | BLA | BLA125115 | 160 | mg/mL |
VIVITE Aftercare Environmental Protection Sunscreen SPF 30 | octinoxate, octisalate, zinc oxide | Cream | HUMAN OTC DRUG | 10/15/2011 | 06/30/2015 | Octinoxate; Octisalate; Zinc Oxide | OTC MONOGRAPH NOT FINAL | part352 | 75; 40; 78 | mg/g; mg/g; mg/g |
VIVITE Daily Facial Moisturizer with Sunscreen SPF 30 | octinoxate, octisalate, oxybenzone | Lotion | HUMAN OTC DRUG | 05/19/2008 | 01/01/1900 | Octinoxate; Octisalate; Oxybenzone | OTC MONOGRAPH NOT FINAL | part352 | 75; 50; 60 | mg/mL; mg/mL; mg/mL |
VUMON | TENIPOSIDE | Injection, Solution | HUMAN PRESCRIPTION DRUG | 07/14/1992 | 07/14/2015 | Teniposide | NDA | NDA020119 | 10 | mg/mL |
Xalatan | latanoprost | Solution | HUMAN PRESCRIPTION DRUG | 03/20/1995 | 01/01/1900 | Latanoprost | NDA | NDA020597 | 50 | ug/mL |
Xanax | alprazolam | Tablet | HUMAN PRESCRIPTION DRUG | 10/16/1981 | 01/01/1900 | Alprazolam | NDA | NDA018276 | 0.25 | mg/1 |
Xanax | alprazolam | Tablet | HUMAN PRESCRIPTION DRUG | 10/16/1981 | 01/01/1900 | Alprazolam | NDA | NDA018276 | 0.5 | mg/1 |
Xanax | alprazolam | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 01/17/2003 | 01/01/1900 | Alprazolam | NDA | NDA021434 | 0.5 | mg/1 |
Xanax | alprazolam | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 01/17/2003 | 01/01/1900 | Alprazolam | NDA | NDA021434 | 1 | mg/1 |
Xanax | alprazolam | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 01/17/2003 | 01/01/1900 | Alprazolam | NDA | NDA021434 | 2 | mg/1 |
Xanax | alprazolam | Tablet, Extended Release | HUMAN PRESCRIPTION DRUG | 01/17/2003 | 01/01/1900 | Alprazolam | NDA | NDA021434 | 3 | mg/1 |
Xanax | alprazolam | Tablet | HUMAN PRESCRIPTION DRUG | 10/16/1981 | 01/01/1900 | Alprazolam | NDA | NDA018276 | 1 | mg/1 |
Xanax | alprazolam | Tablet | HUMAN PRESCRIPTION DRUG | 10/16/1981 | 01/01/1900 | Alprazolam | NDA | NDA018276 | 2 | mg/1 |
Xeloda | capecitabine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/30/1998 | 01/01/1900 | Capecitabine | NDA | NDA020896 | 150 | mg/1 |
Xeloda | capecitabine | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/30/1998 | 01/01/1900 | Capecitabine | NDA | NDA020896 | 500 | mg/1 |
Xenical | orlistat | Capsule | HUMAN PRESCRIPTION DRUG | 12/17/2010 | 01/01/1900 | Orlistat | NDA | NDA020766 | 120 | mg/1 |
Xyzal | levocetirizine dihydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 08/09/2007 | 01/01/1900 | Levocetirizine Dihydrochloride | NDA | NDA022064 | 5 | mg/1 |
Xyzal | levocetirizine dihydrochloride | Solution | HUMAN PRESCRIPTION DRUG | 04/02/2008 | 01/01/1900 | Levocetirizine Dihydrochloride | NDA | NDA022157 | 0.5 | mg/mL |
YERVOY | ipilimumab | Injection | HUMAN PRESCRIPTION DRUG | 03/25/2011 | 01/01/1900 | Ipilimumab | BLA | BLA125377 | 5 | mg/mL |
YERVOY | ipilimumab | Injection | HUMAN PRESCRIPTION DRUG | 03/25/2011 | 01/01/1900 | Ipilimumab | BLA | BLA125377 | 5 | mg/mL |
Zaleplon | Zaleplon | Capsule | HUMAN PRESCRIPTION DRUG | 06/06/2008 | 01/01/1900 | Zaleplon | ANDA | ANDA077237 | 5 | mg/1 |
Zaleplon | Zaleplon | Capsule | HUMAN PRESCRIPTION DRUG | 06/06/2008 | 01/01/1900 | Zaleplon | ANDA | ANDA077237 | 10 | mg/1 |
ZALTRAP | ziv-aflibercept | Solution, Concentrate | HUMAN PRESCRIPTION DRUG | 08/03/2012 | 01/01/1900 | Aflibercept | BLA | BLA125418 | 100 | mg/4mL |
ZALTRAP | ziv-aflibercept | Solution, Concentrate | HUMAN PRESCRIPTION DRUG | 08/03/2012 | 01/01/1900 | Aflibercept | BLA | BLA125418 | 200 | mg/8mL |
Zemaira | alpha-1-proteinase inhibitor human | Kit | PLASMA DERIVATIVE | 07/08/2003 | 01/01/1900 | BLA | BLA125078 | |||
Zemuron | rocuronium bromide | Injection, Solution | HUMAN PRESCRIPTION DRUG | 03/17/1994 | 01/01/1900 | Rocuronium Bromide | NDA | NDA020214 | 10 | mg/mL |
ZERIT | Stavudine | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/1994 | 01/01/1900 | Stavudine | NDA | NDA020412 | 15 | mg/1 |
ZERIT | stavudine | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/1994 | 01/01/1900 | Stavudine | NDA | NDA020412 | 20 | mg/1 |
ZERIT | stavudine | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/1994 | 01/01/1900 | Stavudine | NDA | NDA020412 | 30 | mg/1 |
ZERIT | stavudine | Capsule, Gelatin Coated | HUMAN PRESCRIPTION DRUG | 06/24/1994 | 01/01/1900 | Stavudine | NDA | NDA020412 | 40 | mg/1 |
ZERIT | stavudine | Powder, For Solution | HUMAN PRESCRIPTION DRUG | 09/06/1996 | 01/01/1900 | Stavudine | NDA | NDA020413 | 1 | mg/mL |
Zidovudine | Zidovudine | Tablet | HUMAN PRESCRIPTION DRUG | 09/19/2005 | 01/01/1900 | Zidovudine | ANDA | ANDA076844 | 300 | mg/1 |
Zinecard | dexrazoxane | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/26/1995 | 01/01/1900 | Dexrazoxane Hydrochloride | NDA | NDA020212 | 250 | mg/25mL |
Zinecard | dexrazoxane | Injection, Powder, Lyophilized, For Solution | HUMAN PRESCRIPTION DRUG | 05/26/1995 | 01/01/1900 | Dexrazoxane Hydrochloride | NDA | NDA020212 | 500 | mg/50mL |
ZIOPTAN | TAFLUPROST | Solution | HUMAN PRESCRIPTION DRUG | 02/10/2012 | 01/01/1900 | Tafluprost | NDA | NDA202514 | 0.0045 | mg/.3mL |
ZOCOR | SIMVASTATIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/23/1991 | 01/01/1900 | Simvastatin | NDA | NDA019766 | 40 | mg/1 |
ZOCOR | SIMVASTATIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/23/1991 | 01/01/1900 | Simvastatin | NDA | NDA019766 | 10 | mg/1 |
ZOCOR | SIMVASTATIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/23/1991 | 01/01/1900 | Simvastatin | NDA | NDA019766 | 20 | mg/1 |
ZOCOR | SIMVASTATIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/23/1991 | 01/01/1900 | Simvastatin | NDA | NDA019766 | 5 | mg/1 |
ZOCOR | SIMVASTATIN | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 12/23/1991 | 01/01/1900 | Simvastatin | NDA | NDA019766 | 80 | mg/1 |
ZOLINZA | vorinostat | Capsule | HUMAN PRESCRIPTION DRUG | 10/06/2006 | 01/01/1900 | Vorinostat | NDA | NDA021991 | 100 | mg/1 |
Zoloft | sertraline hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 02/11/1992 | 01/01/1900 | Sertraline Hydrochloride | NDA | NDA019839 | 50 | mg/1 |
Zoloft | sertraline hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 02/11/1992 | 01/01/1900 | Sertraline Hydrochloride | NDA | NDA019839 | 100 | mg/1 |
Zoloft | sertraline hydrochloride | Solution, Concentrate | HUMAN PRESCRIPTION DRUG | 02/11/1992 | 01/01/1900 | Sertraline Hydrochloride | NDA | NDA020990 | 20 | mg/mL |
Zoloft | sertraline hydrochloride | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 02/11/1992 | 01/01/1900 | Sertraline Hydrochloride | NDA | NDA019839 | 25 | mg/1 |
Zolpidem Tartrate | zolpidem tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/27/2007 | 01/01/1900 | Zolpidem Tartrate | ANDA | ANDA077214 | 5 | mg/1 |
Zolpidem Tartrate | zolpidem tartrate | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/27/2007 | 01/01/1900 | Zolpidem Tartrate | ANDA | ANDA077214 | 10 | mg/1 |
ZONTIVITY | vorapaxar | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 05/08/2014 | 01/01/1900 | Vorapaxar Sulfate | NDA | NDA204886 | 2.08 | mg/1 |
ZOSTAVAX | Zoster Vaccine Live | Injection, Powder, Lyophilized, For Suspension | VACCINE | 05/25/2006 | 01/01/1900 | Varicella-zoster Virus Strain Oka/merck Live Antigen | BLA | BLA125123 | 19400 | [PFU]/.65mL |
ZYMAXID | gatifloxacin | Solution/ Drops | HUMAN PRESCRIPTION DRUG | 05/19/2010 | 01/01/1900 | Gatifloxacin | NDA | NDA022548 | 5 | mg/mL |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 01/10/2000 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 15 | mg/1 |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 03/01/2001 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 20 | mg/1 |
ZYPREXA | Olanzapine | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 06/01/2000 | 01/01/1900 | Olanzapine | NDA | NDA021086 | 5 | mg/1 |
ZYPREXA | Olanzapine | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 06/01/2000 | 01/01/1900 | Olanzapine | NDA | NDA021086 | 10 | mg/1 |
ZYPREXA | Olanzapine | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 09/01/2001 | 01/01/1900 | Olanzapine | NDA | NDA021086 | 15 | mg/1 |
ZYPREXA | Olanzapine | Tablet, Orally Disintegrating | HUMAN PRESCRIPTION DRUG | 09/01/2001 | 01/01/1900 | Olanzapine | NDA | NDA021086 | 20 | mg/1 |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 06/23/1997 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 2.5 | mg/1 |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 10/01/1996 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 5 | mg/1 |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 10/01/1996 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 7.5 | mg/1 |
Zyprexa | Olanzapine | Tablet | HUMAN PRESCRIPTION DRUG | 10/01/1996 | 01/01/1900 | Olanzapine | NDA | NDA020592 | 10 | mg/1 |
ZYPREXA | Olanzapine | Injection, Powder, For Solution | HUMAN PRESCRIPTION DRUG | 04/01/2004 | 01/01/1900 | Olanzapine | NDA | NDA021253 | 10 | mg/2mL |
ZYPREXA | Olanzapine pamoate | Kit | HUMAN PRESCRIPTION DRUG | 03/01/2010 | 01/01/1900 | NDA | NDA022173 | |||
ZYPREXA | Olanzapine pamoate | Kit | HUMAN PRESCRIPTION DRUG | 03/01/2010 | 01/01/1900 | NDA | NDA022173 | |||
ZYPREXA | Olanzapine pamoate | Kit | HUMAN PRESCRIPTION DRUG | 03/01/2010 | 01/01/1900 | NDA | NDA022173 | |||
Zyvox | linezolid | Tablet, Film Coated | HUMAN PRESCRIPTION DRUG | 04/18/2000 | 01/01/1900 | Linezolid | NDA | NDA021130 | 600 | mg/1 |
Zyvox | linezolid | Suspension | HUMAN PRESCRIPTION DRUG | 04/18/2000 | 01/01/1900 | Linezolid | NDA | NDA021132 | 100 | mg/5mL |
Zyvox | linezolid | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/18/2000 | 01/01/1900 | Linezolid | NDA | NDA021131 | 200 | mg/100mL |
Zyvox | linezolid | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/18/2000 | 01/01/1900 | Linezolid | NDA | NDA021131 | 400 | mg/200mL |
Zyvox | linezolid | Injection, Solution | HUMAN PRESCRIPTION DRUG | 04/18/2000 | 01/01/1900 | Linezolid | NDA | NDA021131 | 600 | mg/300mL |
Zyvox | linezolid | Injection, Solution | HUMAN PRESCRIPTION DRUG | 06/01/2015 | 01/01/1900 | Linezolid | NDA | NDA021131 | 600 | mg/300mL |